1: (ROOT (NP (NP (NP (DT A) (NNP Scientific) (NNP Look)) (IN at) (NP (NP (NP (NNP Botanical) (NNPS Plants)) (CC and) (NP (NNS Supplements))) (PP (IN Against) (VBN CoronavirusWritten) (PP (IN by) (: :) (NP (NP (NP (NNP Richard) (NNP Gale)) (CC and) (NP (NNP Gary) (NNP Null))) (NP (NNP PhD) (NNP Progressive) (NNP Radio) (NNP Network))))))) (, ,) (NP (NP (NNP March) (CD 10) (, ,) (CD 2020)) (PP (IN In) (NP (JJ recent) (NNS weeks)))) (, ,) (NP (DT the) (NN coronavirus) (NN pandemic)) (VP (VBZ has) (VP (VBN dominated) (NP (DT the) (NN news)) (PP (IN at) (NP (NP (DT the) (NN expense)) (PP (IN of) (NP (NP (NN everything) (RB else)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ critical) (CC and) (JJ urgent)) (PP (IN in) (NP (PRP$ our) (NNS lives)))))))))))) (. .)))
2: (ROOT (S (SBAR (IN As) (S (S (NP (NN panic)) (VP (VBZ increases))) (CC and) (S (NP (JJR more) (NNS cases)) (VP (VBP are) (VP (VBN reported) (ADVP (RB daily))))))) (, ,) (NP (ADJP (NN healt) (HYPH -) (JJ minded)) (NNS people)) (VP (VBP are) (ADJP (JJ eager) (CC or) (RB even) (JJ desperate) (S (VP (TO to) (VP (VB know) (SBAR (IN whether) (S (NP (EX there)) (VP (VBP are) (NP (NP (NNS ways)) (SBAR (S (VP (TO to) (VP (VB strengthen) (NP (NP (DT the) (NN body) (POS 's)) (JJ immune) (NN system)) (S (VP (TO to) (VP (VB offer) (NP (NP (DT some) (NN protection)) (PP (IN from) (NP (DT this) (JJ specific) (NML (JJ upper) (JJ respiratory)) (NN infection)))))))))))))))))))) (. .)))
3: (ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (NP (CD six) (JJ known) (NNS strains)) (PP (IN of) (NP (NN coronavirus)))) (, ,) (NP (NP (CD four)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (DT the) (JJ common) (ADJP (JJ cold) (CC or) (JJ moderate)) (JJ respiratory) (NNS infections)))))))))) (. .)))
4: (ROOT (S (NP (NN Everyone)) (VP (VBZ has) (ADVP (RB likely)) (VP (VBN had) (NP (DT a) (NN coronavirus) (NN infection)) (PP (IN at) (NP (NP (DT some) (NN time)) (PP (IN in) (NP (PRP$ their) (NNS lives))))))) (. .)))
5: (ROOT (S (ADVP (RB However)) (, ,) (NP (NP (CD two) (NNS strains)) (: -) (NP (NP (NP (NNP Severe) (NNP Acute) (NNP Respiratory) (NNP Syndrome)) (CC or) (NP (NNP SARS))) (CC and) (NP (NML (NNP Middle) (NNP East)) (NNP Respiratory) (NNP Syndrome))) (: -)) (VP (VBP are) (ADJP (ADVP (RB much) (RBR more)) (JJ severe))) (. .)))
6: (ROOT (S (PP (IN Between) (NP (NP (DT the) (NNS years)) (NP (NP (CD 200)) (PP (PP (PP (SYM -) (CD 2004)) (CC and) (CD 201) (CD -)) (CD 2018))))) (NP (DT these) (NNS strains)) (ADVP (RB respectively)) (VP (VBD were) (VP (VBN observed) (S (VP (TO to) (VP (VB be) (ADJP (JJ lethal))))))) (. .)))
7: (ROOT (S (ADVP (RB However)) (, ,) (PP (IN during) (NP (DT this) (NNS periods))) (, ,) (NP (JJ total) (NNS deaths)) (VP (VBD were) (NP (QP (JJR less) (IN than) (CD one) (CD thousand)))) (. .)))
8: (ROOT (S (NP (NNP SARS)) (VP (VBZ has) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB infect) (NP (DT the) (JJR lower) (JJ respiratory) (NN system)) (ADVP (RB as) (RB well))))))) (. .)))
9: (ROOT (S (NP (NP (DT The) (JJ current) (NN strain)) (VP (VBG being) (VP (VBN called) (S (NP (CD Cov19)))))) (VP (VBZ is) (NP (NP (DT a) (JJ new) (NN mutation)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBG being) (VP (VBN recognized) (PP (IN as) (NP (DT a) (JJ novel) (NNP SARS)))))))))) (. .)))
10: (ROOT (S (PP (IN As) (PP (IN of) (NP (DT this) (NN writing)))) (, ,) (NP (DT the) (JJ current) (NN coronvirus)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (IN to) (NP (NP (QP (IN over) (CD ,) (CD 000)) (NNS deaths)) (, ,) (NP (NP (DT the) (JJ large) (NN majority)) (PP (IN among) (NP (DT the) (JJ elderly))))))))) (. .)))
11: (ROOT (S (PP (IN In) (NP (DT a) (JJ recent) (NN press) (NN conference))) (NP (DT the) (NNP Surgeon) (NNP General)) (VP (VBD remarked) (SBAR (IN that) (S (NP (NP (DT the) (JJ average) (NN age)) (PP (IN of) (NP (NNS deaths)))) (VP (VBD was) (NP (CD 80)))))) (. .)))
12: (ROOT (S (PP (VBN Compared) (PP (IN to) (NP (NP (NP (JJ other) (JJ viral) (NNS infections)) (SBAR (WHNP (WDT that)) (S (VP (VBP target) (NP (DT the) (JJ respiratory) (NN tract)))))) (, ,) (NP (ADVP (RB especially)) (NN influenza)) (, ,)))) (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (ADJP (RB far) (JJR less)) (NN research)) (S (CC either) (TO to) (VP (VB understand) (NP (NP (NP (DT the) (NN pathway)) (PP (IN of) (NP (NN infection)))) (CC and) (NP (NP (NP (DT the) (NNS drugs)) (CC or) (NP (JJ natural) (NNS substances))) (SBAR (S (VP (TO to) (VP (VB battle) (NP (DT the) (NN virus))))))))))))) (. .)))
13: (ROOT (S (NP (NP (PRP It))) (VP (VBZ remains) (ADJP (ADJP (JJ uncertain)) (SBAR (WHADVP (WRB how) (JJ long)) (S (NP (NN immunity)) (, ,) (SBAR (IN if) (FRAG (NP (DT any)))) (, ,) (VP (VBZ lasts) (PP (IN after) (NP (NN infection)))))))) (. .)))
14: (ROOT (S (ADVP (RB Seemingly)) (, ,) (NP (NN immunity)) (VP (VBZ wanes) (ADVP (RB quickly))) (. .)))
15: (ROOT (S (ADVP (RB Consequently)) (, ,) (SBAR (IN since) (S (NP (NN coronavirus)) (VP (VBZ is) (ADVP (RBS most) (RB often)) (ADJP (JJ responsible) (PP (IN for) (NP (DT a) (ADJP (NN fl) (HYPH -) (JJ like)) (JJ common) (NN cold))))))) (, ,) (NP (VBN recommended) (NML (NN prevention) (CC and) (NN treatment)) (NNS protocols)) (VP (VBP are) (ADJP (RB largely) (JJ similar) (PP (IN to) (NP (DT the) (NN flu))))) (. .)))
16: (ROOT (S (PP (IN During) (NP (DT a) (JJ recent) (NML (NN coronavirus) (NML (NN task) (NN force))) (NN meeting))) (, ,) (NP (NNP Trump)) (VP (VBD asked) (SBAR (IN whether) (S (NP (DT the) (NN flu) (NN vaccine)) (VP (MD would) (VP (VB protect) (PP (IN against) (NP (DT the) (NN coronavirus)))))))) (. .)))
17: (ROOT (S (S (NP (DT The) (NN flu) (NN vaccine)) (VP (VBZ is) (CONJP (RB not) (RB only)) (ADJP (NN influenz) (HYPH -) (JJ specific)))) (, ,) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB also)) (ADJP (NP (NN flu) (NN strain)) (JJ specific)))) (. .)))
18: (ROOT (S (NP (PRP It)) (VP (VBZ offers) (NP (NP (ADJP (RB absolutely) (DT no)) (NN protection)) (PP (IN to) (NP (DT any) (JJ other) (NNS viruses))))) (. .)))
19: (ROOT (S (ADVP (RB Nevertheless)) (NP (PRP we)) (VP (VBP are) (VP (VBG going) (S (VP (TO to) (ADVP (RB likely)) (VP (VB witness) (NP (NP (DT a) (JJ sharp) (NN rise)) (PP (IN in) (NP (NP (NN propaganda)) (VP (VBG recommending) (NP (NP (NN flu) (NNS vaccines)) (SBAR (S (VP (TO to) (VP (VB fight) (NP (DT the) (NN coronavirus) (NN scare)))))))))))))))) (. .)))
20: (ROOT (S (NP (DT The) (NN belief)) (VP (VBZ is) (SBAR (IN that) (S (NP (VBG increasing) (NP (JJ national) (NML (NN flu) (NN vaccination)) (NN compliance))) (VP (MD will) (CONJP (RB not) (RB only)) (VP (VB reduce) (NP (NP (DT the) (NNS risks)) (PP (IN of) (NP (NN flu) (NN infection))))) (CC but) (VP (MD will) (ADVP (RB also)) (VP (VB help) (S (VP (VB divert) (NP (NN money)) (ADVP (RB away) (PP (IN from) (NP (NN flu) (NNS infections)))) (S (VP (TO to) (ADVP (RB better)) (VP (VB deal) (PP (IN with) (NP (DT the) (VBG rising) (NN coronavirus) (NNS cases)))))))))))))) (. .)))
21: (ROOT (S (CC But) (NP (EX there)) (VP (VBZ is) (NP (DT a) (NN caveat))) (. .)))
22: (ROOT (NP (DT A) (ADJP (RB very) (JJ serious)) (NN caveat) (. .)))
23: (ROOT (S (ADVP (RB Sometimes)) (NP (DT the) (NN universe)) (VP (VBZ has) (NP (NP (DT an) (JJ unusual) (NN way)) (PP (IN of) (S (VP (VBG providing) (NP (NNS warnings) (SBAR (IN that) (S (NP (PRP we)) (VP (VBP have) (NP (DT an) (NN opportunity) (S (VP (TO to) (VP (CC either) (VB heed) (CC or) (VB disregard) (PP (IN to) (NP (PRP$ our) (NN benefit) (CC or) (NN detriment)))))))))))))))) (. .)))
24: (ROOT (S (PP (IN On) (NP (NNP December) (CD 31) (, ,) (CD 2019))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB usher) (PP (IN in) (NP (DT the) (NNP New) (NNP Year))))))) (, ,) (NP (NNP China)) (VP (VBD reported) (NP (NP (DT the) (JJ first) (NN case)) (PP (IN of) (NP (DT an) (`` `) (JJ unusual) (NN pneumonia) ('' '))) (PP (IN in) (NP (NP (PRP$ its) (NN port) (NN city)) (PP (IN of) (NP (NNP Wuhan))))))) (. .)))
25: (ROOT (S (ADVP (ADVP (NP (DT A) (NN week)) (RB later)) (PP (IN on) (NP (NNP January) (NNP 7th)))) (, ,) (NP (DT the) (NN pathogen)) (VP (VBD was) (VP (VBN identified) (PP (IN as) (NP (NP (DT a) (JJ novel) (NN strain)) (PP (IN of) (NP (NN coronavirus))))))) (. .)))
26: (ROOT (S (NP (DT That) (JJ same) (NN month)) (, ,) (NP (NP (DT the) (JJ prestigious) (NN journal)) (NP (NNP Vaccine))) (, ,) (VP (VBD published) (NP (NP (DT a) (NN study)) (VP (VBN conducted) (PP (IN by) (NP (NP (DT the) (NML (NNP Armed) (NNP Forces)) (NML (NNP Health) (NNP Surveillance)) (NNP Branch)) (PP (IN at) (NP (NML (NNP Wright) (NNP Patterson)) (NML (NNP Air) (NNP Force)) (NNP Base)))))))) (. .)))
27: (ROOT (S (S (NP (NNS Researchers)) (VP (VBD investigated) (NP (NP (JJ viral) (NN interference)) (PP (IN due) (IN to) (S (VP (VBG receiving) (NP (DT the) (NN flu) (NN shot)))))))) (: ;) (S (PP (IN in) (NP (JJ other) (NNS words))) (, ,) (VBZ does) (NP (DT the) (NN flu) (NN vaccine)) (VP (VB make) (S (NP (DT a) (NN recipient)) (ADJP (RBR more) (JJ susceptible) (PP (IN to) (NP (JJ other) (NML (DT no) (HYPH -) (NN influenza)) (JJ respiratory) (JJ viral) (NNS infections))))))) (. ?)))
28: (ROOT (S (NP (NP (DT The) (NN study) (POS 's)) (NNS conclusions)) (VP (VBP state) (`` `) (SBAR (S (NP (ADJP (NNP Vaccine) (VBN derived)) (NN virus) (NN interference)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN associated) (PP (IN with) (NP (NP (NN coronavirus)) (CC and) (NP (JJ human) (NN metapneumovirus))))))))) (. .) ('' ')))
29: (ROOT (S (NP (DT This)) (VP (VBZ is) (RB not) (NP (NP (DT the) (JJ first) (NN time)) (SBAR (WHADVP (IN that)) (S (NP (NP (JJ viral) (NN interference)) (PP (IN from) (NP (DT the) (NN flu) (NN vaccine)))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NML (DT no) (HYPH -) (NN influenza)) (JJ respiratory) (NNS infections)))))))))))) (. .)))
30: (ROOT (S (NP (NP (DT A) (ADJP (ADVP (RB much) (RBR more)) (JJ thorough)) (NN study)) (, ,) (NP (DT an) (JJ actual) (JJ clinical) (NN trial)) (, ,)) (VP (VBD was) (VP (VBN conducted) (PP (IN by) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Hong) (NNP Kong))))) (PP (IN in) (NP (CD 2012))))) (. .)))
31: (ROOT (S (NP (DT The) (NML (JJ double) (JJ blind)) (VBN randomized) (VBN controlled) (NN trial)) (VP (VBD followed) (NP (NP (DT a) (NN group)) (PP (PP (IN of) (NP (ADJP (ADJP (NN fl) (HYPH -) (VBN vaccinated)) (CC versus) (ADJP (NN placeb) (HYPH -) (VBN vaccinated))) (NNS children)) (PP (IN between) (NP (NP (QP (CD 6) (CC and) (CD 15)) (NNS years)) (PP (IN of) (NP (NN age)))))) (PP (IN over) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (CD nine) (NNS months))))))) (S (VP (TO to) (VP (VB determine) (NP (NP (NN infection) (NNS rates)) (PP (IN from) (NP (CD 19) (JJ other) (JJ respiratory) (NNS viruses)))))))) (. .)))
32: (ROOT (S (NP (DT The) (NN study)) (VP (VBD found) (`` `) (NP (NP (DT no) (ADJP (RB statistically) (JJ significant)) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (VBN confirmed) (NML (JJ seasonal) (NN influence)) (NN influenza) (NN infection))))) (PP (IN between) (NP (NP (NNS recipients)) (PP (IN of) (NP (NP (DT the)) (CC or) (NP (NN placebo)))))))) (. .) ('' ')))
33: (ROOT (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBD was) (NP (NP (NP (DT the) (JJ dramatic) (NN number)) (PP (IN of) (NP (NP (NP (NNS incidences)) (PP (IN of) (NP (NML (DT no) (HYPH -) (NN influenza)) (NNS infections)))) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (ADJP (NN fl) (HYPH -) (VBN vaccinated)) (NN group)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD included) (NP (NN coronavirus))))))))))) (, ,) (RB as) (S (VP (VBN opposed) (PP (IN to) (NP (NP (CD 54) (NNS cases)) (PP (IN among) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (DT a) (NN placebo))))))))))))) (. .)))
34: (ROOT (S (PP (IN In) (NP (JJ other) (NNS words))) (, ,) (NP (DT the) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (S (VP (VBG receiving) (NP (DT the) (NN flu) (NN shot)))) (VP (MD may) (VP (VB increase) (NP (NP (NP (PRP one) (POS 's)) (NN risk)) (PP (IN of) (S (VP (VBG contracting) (NP (DT another) (JJ infectious) (NN virus)))))) (PP (IN by) (NP (QP (RB almost) (CD 100)) (NN percent)))))))) (. .)))
35: (ROOT (S (NP (NP (NP (DT A) (JJ recent) (NN analysis)) (PP (IN out) (PP (IN of) (NP (NNP China))))) (VP (VBG reviewing) (NP (NP (NNS rates)) (PP (IN of) (NP (NP (NN infection)) (, ,) (NP (JJ targeted) (NNS populations)) (CC and) (NP (NN mortality))))))) (VP (VBD reported) (SBAR (IN that) (S (NP (DT the) (JJS worst) (VBN hit) (NN group)) (VP (VBZ is) (NP (NP (NP (NP (JJR older) (NNS people)) (, ,) (NP (ADVP (RB particularly)) (NP (DT those)))) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (ADJP (NN immun) (HYPH -) (VBN compromised)) (NNS conditions)))))) (: :) (NP (NP (JJ cardiovascular) (NN disease)) (, ,) (NP (NN hypertension)) (, ,) (NP (NN diabetes)) (, ,) (NP (JJ chronic) (JJ respiratory) (NNS illnesses)) (, ,) (RB et))))))) (. ..)))
36: (ROOT (S (S (VP (VBG Taking) (NP (DT this) (NN statistic)) (PP (IN into) (NP (NN account))))) (, ,) (NP (PRP we)) (VP (MD may) (VP (VB note) (SBAR (IN that) (S (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (JJ American) (NNS adults)))) (VP (VBP have) (NP (NP (DT some) (NN type)) (PP (IN of) (NP (JJ chronic) (NN condition))))))))) (. .)))
37: (ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN estimated) (SBAR (IN that) (S (S (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (JJ American) (NNS adults)))) (VP (VBP have) (NP (QP (ADVP (RB at) (RBS least)) (CD one)) (VBG underlying) (NN health) (NN condition)))) (CC and) (S (NP (CD 40) (NN %)) (VP (VBP have) (NP (CD two) (CC or) (JJR more)))))))) (. .)))
38: (ROOT (S (PP (IN For) (NP (NN example))) (, ,) (S (NP (QP (CD 33) (CD million))) (VP (VBP have) (NP (NN diabetes)))) (CC and) (S (S (NP (DT an) (VBN estimated) (QP (CD 84) (CD million))) (VP (VBP are) (ADJP (JJ pr) (HYPH -) (JJ diabetic)))) (: ;) (S (NP (NN heart) (NN disease)) (VP (VBZ affects) (NP (QP (CD 121) (CD million)))))) (CC and) (S (NP (EX there)) (VP (VBP are) (NP (QP (RB approximately) (CD .7) (CD million)) (JJ new) (NN cancer) (NNS diagnoses)) (ADVP (RB annually)))) (. .)))
39: (ROOT (S (NP (NP (DT All)) (PP (IN of) (NP (DT these) (NNS people)))) (, ,) (ADVP (RB therefore)) (, ,) (VP (VBP have) (ADVP (CC either)) (NP (DT a) (ADJP (JJ mild) (IN to) (JJ severe)) (VBN compromised) (JJ immune) (NN system))) (. .)))
40: (ROOT (S (NP (DT A) (JJ Swiss) (NN study)) (VP (VBD noted) (SBAR (IN that) (S (NP (DT the) (NML (NML (NNP SARS) (NN coronavirus)) (CC and) (NML (NN influenza)))) (VP (VBP share) (NP (NP (NP (CD two)) (PP (IN of) (NP (DT the) (JJ same) (NNS proteases))) (PP (IN in) (NP (VBN targeted) (NNS cells)))) (: -) (NP (CD TMPRSS2) (CC and) (NNP HAT))))))) (. .)))
41: (ROOT (S (NP (DT These)) (VP (VP (VBP are) (ADJP (JJ responsible) (PP (IN for) (S (VP (VBG activating) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (DT the) (NN virus)))) (PP (IN at) (NP (NP (DT the) (NN point)) (PP (IN of) (NP (NN infection)))))))))) (CC and) (VP (VBP contribute) (PP (IN to) (NP (NP (PRP$ their) (NN pathogenesis)) (PP (IN in) (NP (DT an) (JJ infected) (NN cell))))))) (. .)))
42: (ROOT (S (ADVP (RB Therefore)) (NP (NP (PRP it))) (VP (MD may) (VP (VB be) (NP (RB partially) (NN conjecture)) (PP (IN on) (NP (PRP$ our) (NN part))) (S (VP (TO to) (VP (VB suggest) (SBAR (IN that) (S (NP (NP (NP (JJ natural) (NNS supplements)) (CC and) (NP (JJ botanical) (NNS remedies))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN shown) (PP (IN in) (NP (DT the) (JJ scientific) (NN literature))) (S (VP (TO to) (VP (VB be) (ADJP (JJ effective) (PP (IN against) (NP (NN influenza))))))))))))) (VP (MD may) (ADJP (ADVP (RBR more) (CC or) (RBR less)) (JJ effective) (PP (IN against) (NP (NN coronavirus)))) (ADVP (RB as) (RB well)))))))))) (. .)))
43: (ROOT (S (PP (IN In) (NP (NN fact))) (, ,) (NP (JJ last) (NN month)) (NP (DT a) (NN study)) (VP (VBD was) (VP (VBN released) (PP (IN by) (NP (NP (NNP Shengjing) (NNP Hospital)) (PP (IN of) (NP (NNP China) (NNP Medical) (NNP University))))) (PP (IN in) (NP (NP (DT the) (NNP Journal)) (PP (IN of) (NP (NNP Medical) (NNP Virology))))) (VP (VBG recommending) (SBAR (IN that) (S (NP (NP (NNS patients) (POS ')) (JJ nutritional) (NN status)) (VP (MD should) (VP (VB be) (VP (VBN evaluated) (PP (IN before) (NP (DT any) (JJ conventional) (NN treatment))))))))))) (. .)))
44: (ROOT (S (NP (DT The) (NN hospital)) (VP (VP (VBD recommended) (NP (NP (DT a) (NN regimen)) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (NP (NP (NNS Vitamins) (NN A) (, ,) (NNP B) (, ,) (NNP C) (, ,) (NNP D) (, ,) (NNP E) (, ,) (NP (CD Omeg-3)) (, ,) (NP (NP (NNP Selenium)) (, ,) (NP (NN Zinc))) (, ,) (NP (NN gammaglobulin) (NNP A))) (VP (VP (VBN administered) (ADVP (RB intravenously))) (CC and) (NP (JJ Chinese) (JJ traditional) (NN medicine))))))))) (RB Therefore) (S (NP (PRP we)) (VP (VBP have) (VP (VBN scoured) (NP (NP (DT the) (ADJP (NN pee) (HYPH -) (VBN reviewed)) (NN literature)) (PP (IN on) (NP (NP (NP (DT the) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health))) (POS 's)) (NML (NML (NNP Library)) (PP (IN of) (NP (NNP Medicine)))) (NN database)))) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ compelling) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB warrant) (NP (UCP (NN vitamin) (, ,) (NN antioxidant) (, ,) (CC and) (JJ botanical)) (NN supplementation)) (PP (IN as) (NP (NP (DT a) (NN means)) (SBAR (S (VP (TO to) (VP (VB protect) (NP (PRP ourselves)) (PP (IN from) (NP (NP (NN coronavirus)) (CC and) (NP (JJ other) (JJ viral) (NNS infections)))))))))))))))))))))) (. .)))
45: (ROOT (S (NP (DT These)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (CC either) (VP (VBP have) (NP (JJ strong) (JJ antiviral) (NNS properties)) (PP (IN in) (ADJP (JJ general)))) (CC or) (VP (VBP have) (NP (NP (VBN known) (JJ biomolecular) (NNS effects)) (SBAR (S (VP (TO to) (VP (VB strengthen) (NP (DT the) (JJ immune) (NN system)) (PP (IN against) (NP (JJ microbial) (NN infection))))))))))))))) (. .)))
46: (ROOT (S (NP (PRP We)) (VP (VBP are) (RB not) (VP (VBG offering) (NP (NNS prescriptions)))) (. .)))
47: (ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (RB just) (DT a) (NN summary)) (PP (IN of) (NP (NP (DT some) (JJ important) (JJ scientific) (NN information)) (SBAR (IN for) (S (NP (PRP you)) (VP (TO to) (VP (VB make) (NP (NP (ADJP (RBR better) (VBN informed)) (NNS decisions)) (PP (IN for) (S (VP (VBG protecting) (NP (PRP yourself)))))) (SBAR (IN while) (S (NP (DT the) (NN coronavirus)) (VP (VBZ wends) (NP (PRP$ its) (NN course))))))))))))) (. .)))
48: (ROOT (NP (NNS BOTANICALS) (: :)))
49: (ROOT (S (S (NP (NNP Astragulus)) (VP (VBZ is) (CONJP (RB not) (RB only)) (NP (NP (DT a) (ADJP (RB very) (JJ popular)) (NN plant)) (VP (VBN used) (PP (IN in) (NP (NNP TCM))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (VBN researched) (CC and) (JJ promising)) (JJ botanical) (NNS plants)) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (JJ antiviral) (NNS properties))))))))))) (. .)))
50: (ROOT (S (PP (PP (IN In) (NP (DT both) (NNP TCM) (CC and) (NNP Ayruveda))) (JJ medicinal) (NNS formulas)) (NP (NNP astrugulus)) (VP (VBZ has) (VP (VBN been) (VP (VBN prescribed) (PP (IN for) (NP (NNS centuries))) (PP (IN because) (IN of) (NP (NP (PRP$ its) (NN effectiveness)) (PP (IN against) (NP (NP (NNS infections)) (CC and) (NP (ADJP (NN ove) (HYPH -) (VBN stressed)) (JJ respiratory) (NNS conditions))))))))) (. .)))
51: (ROOT (S (NP (NP (NP (NNS Compounds)) (, ,) (NP (ADVP (RB notably)) (NNS saponins))) (, ,) (VP (VBN found) (PP (IN in) (NP (NN astragulus))))) (VP (VBP have) (VP (VBN been) (VP (VP (ADVP (RB well)) (VP (VBN researched))) (CC and) (VP (VBN found) (S (VP (TO to) (VP (VB hinder) (NP (NN influenza) (NN proliferation))))))))) (. .)))
52: (ROOT (S (NP (NP (NP (DT The) (NNP US) (NNP Department)) (PP (IN of) (NP (NNP Agriculture))) (POS 's)) (NML (NNP Avian) (NNP Disease) (CC and) (NNP Oncology)) (NNP Laboratory)) (VP (VBD found) (SBAR (S (NP (PRP it)) (VP (VBZ inhibits) (NP (NML (NN avian) (NN flu)) (NNS viruses)))))) (. .)))
53: (ROOT (S (NP (NP (NNP Jinlin) (NNP Academy)) (PP (IN of) (NP (NNP Agricultural) (NNPS Sciences))) (PP (IN in) (NP (NNP China)))) (VP (VP (VBD conducted) (NP (NP (NP (DT a) (NN study)) (VP (VBN published) (PP (IN in) (NP (NP (DT the) (NN journal)) (NP (NNP Microbiological) (NNP Pathology)))))) (SBAR (WHNP (WDT that)) (S (VP (VBD concluded) (`` `) (S (NP (NNP Astragulus)) (VP (VBZ exhibits) (NP (NP (JJ antiviral) (NNS properties)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB treat) (NP (NP (JJ infectious) (NN bronchitis)) (VP (VBN caused) (PP (IN by) (NP (NN coronavirus))))))))))))))))) ('' '))))
54: (ROOT (S (NP (JJ Chinese) (NNS farmers)) (VP (MD will) (ADVP (RB often)) (VP (VB use) (NP (NN astragulus)) (PP (IN in) (NP (NN feed))) (S (VP (TO to) (VP (VB protect) (NP (DT the) (NNS birds)) (PP (PP (IN from) (NP (NN infection))) (CONJP (RB as) (RB well) (IN as)) (NP (NN pig) (NN feed))) (S (VP (TO to) (VP (VB ward) (PRT (RP off)) (NP (JJ porcine) (NN circovirus)))))))))) (. .)))
55: (ROOT (S (ADVP (NP (CD Two) (NNS weeks)) (RB ago)) (, ,) (NP (NP (NNP Beijing) (NNP University)) (PP (IN of) (NP (NNP Chinese) (NNP Medicine)))) (VP (VBD completed) (NP (NP (NP (DT an) (NN analysis)) (PP (IN of) (NP (JJ previous) (NN research)))) (VP (VBG looking) (PP (IN at) (NP (NP (DT the) (NNS benefits)) (PP (IN of) (NP (JJ Chinese) (JJ herbal) (NNS formulas))) (PP (IN against) (NP (DT the) (NML (NML (NNP SARS) (NN coronavirus)) (CC and) (NML (CD H1N1) (NN flu)))))))))) (. .)))
56: (ROOT (S (PP (IN In) (NP (CD 3) (NNS studies))) (, ,) (PP (IN among) (NP (NP (NNS participants)) (SBAR (WHNP (WP who)) (S (VP (VBD took) (NP (NP (NNS formulas)) (PP (IN against) (NP (NNP SARS))))))))) (, ,) (NP (NN none)) (VP (VBD contracted) (NP (DT the) (NN illness))) (. .)))
57: (ROOT (SINV (CC Nor) (VBD did) (NP (NP (DT any)) (VB contract) (NP (CD H1N1) (NN influenza))) (PP (IN in) (NP (CD four) (JJ additional) (NNS studies))) (. .)))
58: (ROOT (S (NP (NP (DT A) (JJ primary) (NN ingredient)) (PP (IN in) (NP (DT these) (NNS formulas) (POS ')))) (VP (VBD was) (NP (NN astragulus))) (. .)))
59: (ROOT (S (ADVP (ADVP (RBR Earlier)) (PP (IN in) (NP (NNP February)))) (, ,) (NP (NP (NNS researchers)) (PP (IN at) (NP (NP (NP (NNP Beijing) (NNPS Children) (POS 's)) (NNP Hospital)) (PP (IN at) (NP (DT the) (NNP Capital) (NNP Medical) (NNP University)))))) (VP (VBD provided) (NP (NP (DT a) (JJ thorough) (NN overview)) (PP (IN of) (NP (NP (VBN recommended) (NML (NML (JJ diagnostic) (NNS procedures)) (CC and) (NML (NNS treatments)))) (PP (IN for) (NP (NP (NP (JJ specific) (NNS symptoms)) (VP (VBN witnessed) (PP (IN in) (NP (DT the) (JJ current) (CD Cov19) (NNS infections))))) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (NP (ADJP (DT both) (JJ allopathic) (CC and) (JJ traditional)) (JJ Chinese) (NN medicine))))))))))) (. .)))
60: (ROOT (S (PP (IN In) (NP (NP (NNS cases)) (SBAR (WHADVP (WRB where)) (S (NP (EX there)) (VP (VBP are) (NP (NP (NP (NNS signs)) (PP (IN of) (NP (JJ severe) (NN weakness) (CC and) (NN stress)))) (VP (VBN observed) (PP (IN in) (NP (DT the) (NNS lungs) (CC and) (NN spleen)))))))))) (, ,) (NP (NP (DT a) (NN formula)) (VP (VBN called) (S (NP (NNP Liu) (NNP Jun) (NNP Zi))))) (VP (VBZ is) (VP (VBG being) (VP (VBN prescribed) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ includes) (NP (NN astragulus) (CC and) (NN ginseng)) (PP (IN as) (NP (CD two) (JJ primary) (NNS botanicals))))))))) (. .)))
61: (ROOT (S (NP (JJ Last) (NN week)) (, ,) (NP (NP (DT the) (JJ prestigious) (NN journal)) (NP (NNP Science))) (VP (VBD published) (NP (NP (NP (DT a) (NN review)) (PP (IN out) (PP (IN of) (NP (NP (NML (NNP Yu) (HYPH -) (NNP nan)) (NNP Academy)) (PP (IN of) (NP (NNP Agricultural) (NNPS Sciences))) (PP (IN in) (NP (NNP China))))))) (SBAR (WHNP (WDT that)) (S (VP (VBD investigated) (NP (NP (DT the) (JJ great) (NNS disparities)) (PP (IN in) (NP (NML (NN infection) (CC and) (NN mortality)) (NNS rates))) (PP (IN between) (NP (JJ different))))))))) (: provinces-)))
62: (ROOT (S (PP (IN In) (NP (NP (DT the) (NNS provinces)) (PP (IN with) (NP (DT the) (JJS lowest) (NN infection) (NNS rates))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (IN between) (DT an) (NML (QP (CD 84) (NN %) (IN to) (CD 98) (NN %))) (NN use)) (PP (IN of) (NP (NNP TCM) (NNS formulas))))) (. .)))
63: (ROOT (S (ADVP (RB Again)) (, ,) (NP (NP (CD two)) (PP (IN of) (NP (DT the) (JJ main) (NNS ingredients)))) (VP (VBD were) (NP (NNP Astragulus) (CC and) (NNP Ginseng))) (. .)))
64: (ROOT (S (NP (NP (NN Licorice) (NNP Root)) (PP (IN In) (NP (JJ traditional) (NN medicine)))) (NP (NN licorice) (NN root)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB relieve) (CC and) (VB treat) (NP (NP (NNS ulcers)) (, ,) (NP (JJ sore) (NNS throats)) (, ,) (NP (NN bronchitis)) (, ,) (NP (NNS coughs)) (, ,) (NP (NN adrenal) (NNS insufficiencies)) (CC and) (NP (JJ allergic) (NNS diseases))))))))) (. .)))
65: (ROOT (S (NP (NP (JJ Ancient) (NNS manuscripts)) (PP (IN from) (NP (NNP China) (, ,) (NNP India) (CC and) (NNP Greece)))) (DT all) (VP (VBP include) (NP (NP (NN licorice)) (PP (IN for) (S (VP (VBG treating) (NP (NP (NML (JJ respiratory) (NN tract)) (NNS infections)) (CC and) (NP (NNS hepatitis)))))))) (. .)))
66: (ROOT (S (PP (IN In) (NP (NNP China) (CC and) (NNP Japan))) (NP (NP (NN licorice) (POS 's)) (JJ main) (JJ antiviral) (NNS compounds)) (VP (VBP are) (VP (VBN known) (PP (IN as) (NP (NNS glycyrrhizins))))) (. .)))
67: (ROOT (S (PP (IN For) (NP (CD 20) (NNS years))) (NP (NNS glycyrrhizins)) (VP (VBP have) (VP (VBN been) (VP (VBN used) (ADVP (RB intravenously)) (S (VP (TO to) (VP (VB treat) (NP (JJ chronic) (NML (NN hepatitis) (NNP B) (CC and) (NNP C)) (NNS infections)) (PP (IN with) (NP (ADJP (RB very) (JJ rare)) (JJ side) (NNS effects))))))))) (. .)))
68: (ROOT (S (NP (PRP It)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VP (VB induce) (NP (NN apoptosis)) (PP (IN in) (NP (NN lymphoma) (NNS cells)))) (CC and)))))))))
69: (ROOT (S (ADVP (RB Therefore)) (NP (NP (PRP it))) (VP (VBD was) (NP (DT an) (JJ unexpected) (NN surprise)) (S (VP (TO to) (VP (VB discover) (SBAR (IN that) (S (NP (EX there)) (VP (VBZ is) (NP (NP (JJ notable) (NN research)) (PP (IN on) (NP (NP (NP (NN glycyrrihizin) (POS 's)) (NN effectiveness)) (PP (IN against) (NP (NP (NN coronavirus)) (CC and) (PP (PP (IN in) (ADJP (JJ particular))) (NNP SARS)))))))))))))) (. .)))
70: (ROOT (S (NP (NP (NP (NNP Japan) (POS 's)) (NNP National) (NNP Institute)) (PP (IN of) (NP (NNP Infectious) (NNP Disease)))) (VP (VBD reported) (NP (NP (NP (NNP GL) (POS 's)) (NN effectiveness)) (PP (IN against) (NP (NP (NP (NN coronavirus)) (CC and) (NP (JJ severe) (JJ acute) (NN respiratory) (NN syndrome))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NML (NNP Epstein) (NNP Barr)) (NN virus)) (CC and) (NP (JJ human) (NN cytomegalovirus))))))) (. .)))
71: (ROOT (S (PP (IN After) (NP (NP (DT the) (JJ deadly) (NNP SARS) (NN outbreak)) (PP (IN in) (NP (CD 2012))))) (, ,) (NP (NP (NNS virologists)) (PP (IN at) (NP (NML (NNP Frankfurt) (NNP University)) (NNP Medical) (NNP School)))) (VP (VBD investigated) (NP (NP (JJ several) (JJ antiviral) (NNS compounds)) (SBAR (S (VP (TO to) (VP (VB treat) (NP (NP (NNS patients)) (VP (VBN admitted) (PP (IN with) (NP (NML (NNP SARS) (NN coronavirus)) (NNS infections))))))))))) (. .)))
72: (ROOT (S (PP (IN Of) (NP (NP (PDT all) (DT the) (NNS compounds)) (VP (VBN tested)))) (, ,) (NP (NP (NNP licorice) (POS 's)) (NNP GL)) (VP (VBD was) (NP (DT the) (ADJP (RBS most) (JJ effective)))) (. .)))
73: (ROOT (S (NP (DT The) (NNS scientists)) (VP (VBD concluded) (SBAR (IN that) (`` `) (S (NP (PRP$ Our) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN glycyrrhizin)) (VP (MD should) (VP (VB be) (VP (VBN assessed) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (NNP SARS)))))))))))))) (. .) ('' ')))
74: (ROOT (S (NP (DT The) (JJ above) (NN research)) (VP (VBD was) (ADVP (RB later)) (VP (VP (VBN replicated) (PP (IN at) (NP (NP (NML (NNP Sun) (NNP Yat) (NNP Sen)) (NNP University)) (PP (IN in) (NP (NNP China)))))) (CC and) (VP (VBN published) (PP (IN in) (NP (NP (DT the) (JJ Chinese) (NN journal)) (NP (NNP Bing) (NNP Du) (NNP Xue) (NNP Bao))))))) (. .)))
75: (ROOT (S (NP (DT The) (NNS researchers)) (VP (VBD identified) (NP (NP (JJ several) (NNS derivatives)) (PP (IN of) (NP (NN glycyrrhizin)))) (PP (IN as) (NP (NP (JJ primary) (NNS molecules)) (PP (IN with) (NP (JJ antiviral) (NNS properties)))))) (. .)))
76: (ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (S (VP (VBG being) (ADJP (JJ effective) (PP (IN against) (NP (DT the) (NNP SARS) (NN coronavirus))))))))) (, ,) (NP (PRP they)) (ADVP (RB also)) (VP (VBD found) (SBAR (S (NP (PRP it)) (VP (MD may) (VP (VB be) (ADJP (JJ effective) (PP (IN against) (NP (NP (NNS herpes)) (, ,) (NP (NNP HIV)) (, ,) (NNP hepatitis) (CC and) (NN influenza))))))))) (. .)))
77: (ROOT (S (ADVP (ADVP (RBR Earlier)) (PP (IN in) (NP (CD 2005)))) (, ,) (NP (NP (DT a) (NN team)) (PP (IN of) (NP (NNS scientists))) (PP (IN from) (NP (NP (NP (NNP Goethe) (NNP University)) (PP (IN in) (NP (NNP Germany)))) (CC and) (NP (NP (DT the) (NNP Russian) (NNP Academy)) (PP (IN of) (NP (NNPS Sciences))))))) (VP (VBD had) (ADVP (RB already)) (VP (VBN identified) (NP (NP (DT the) (JJ antiviral) (NN activity)) (PP (IN of) (NP (NNP GL))) (PP (IN against) (NP (NNP SARS) (NN coronavirus)))))) (. .)))
78: (ROOT (S (NP (DT The) (NN molecule)) (VP (VBD showed) (NP (NP (DT a) (NML (JJ te) (HYPH -) (NN fold)) (NN increase)) (PP (IN in) (NP (NML (NN ant) (HYPH -) (NNP SARS)) (NN activity))) (PP (VBN compared) (PP (IN to) (NP (NP (JJ other) (JJ potential) (NNS treatments)) (VP (VBN tested))))))) (. .)))
79: (ROOT (S (NP (NP (CD One) (NN conjugate)) (PP (IN of) (NP (NNP GL)))) (VP (VBD had) (NP (DT a) (NML (CD 7) (HYPH -) (NN fold)) (NN increase))) (. .)))
80: (ROOT (S (NP (DT That) (NN study)) (VP (VBD was) (VP (VBN published) (PP (IN in) (NP (NP (DT the) (NNP Journal)) (PP (IN of) (NP (NNP Medical) (NNP Chemistry))))))) (. .)))
81: (ROOT (S (PP (IN During) (NP (DT that) (JJ same) (NN year))) (, ,) (NP (NP (DT the) (NNP Chinese) (NNP Academy)) (PP (IN of) (NP (NNPS Sciences)))) (VP (VBD screened) (NP (NP (QP (RB over) (CD 200)) (JJ botanical) (NNS plants)) (VP (VBN used) (PP (IN in) (NP (NNP Traditional) (NNP Chinese) (NNP Medicine))))) (S (VP (TO to) (VP (VB find) (NP (NP (DT those)) (PP (IN with) (NP (NP (DT the) (JJ strong) (NN potency)) (NP (NNP SARS) (NN coronavirus))))))))) (. .)))
82: (ROOT (S (NP (CD Four) (NNS botanicals)) (VP (VBD stood) (PRT (RP out))) (. .)))
83: (ROOT (S (S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (CD four)))) (VP (VBD was) (NP (NP (NP (NP (NN licorice) (POS 's)) (NN glycyrrhizin) (NNP Extract)) (PP (IN of) (NP (NN licorice) (NN root)))) (VP (VBZ is) (NP (DT the) (ADJP (RBS most) (JJ effective))))))) (CC and) (S (NP (NN glycyrrhizin)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ available) (PP (IN as) (NP (DT a) (JJ separate) (JJ botanical) (NN supplement)))))) (. .)))
84: (ROOT (S (NP (NNP Elderberry) (NNP Elderberry)) (VP (VBZ has) (VP (VBN become) (NP (NP (DT a) (JJ popular) (NN supplement)) (PP (IN for) (S (VP (VBG relieving) (NP (NP (NNS symptoms)) (PP (IN of) (NP (DT the) (JJ common) (NML (NN cold) (CC and) (NN flu)) (NNS infections)))))))))) (. .)))
85: (ROOT (S (NP (PRP It)) (VP (VP (VBZ is) (VP (VBN found) (S (ADJP (JJ wild))) (ADVP (RB worldwide)))) (CC and) (VP (VBZ is) (NP (NP (NN part)) (PP (IN of) (NP (NP (JJ many)) (PP (IN of) (NP (NP (DT the) (NN world) (POS 's)) (JJ indigenous) (NNS pharmacopias)))))))) (. .)))
86: (ROOT (S (S (NP (EX There)) (VP (VBP are) (NP (NP (JJ many) (NNS species)) (PP (IN of) (NP (NN elderberry)))))) (: ;) (S (NP (NP (DT the) (NN species)) (NP (NNP Sambucus) (NNP nigra))) (ADVP (RB seemingly)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (DT the) (ADJP (JJS most) (JJ medicinal)) (NNS qualities))))))))) (. .)))
87: (ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBG purchasing) (NP (NNP Elderberry) (CC or) (NNP Sambucus))))) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (VP (VBN recommended) (S (VP (TO to) (VP (VB note) (SBAR (S (NP (PRP it)) (VP (VBZ is) (NP (NNP Sambucus) (NN nigra)))))))))) (. .)))
88: (ROOT (S (NP (NP (PRP It))) (VP (VBZ is) (ADJP (JJR better)) (S (VP (TO to) (VP (VP (VB use) (NP (DT a) (VBN prepared) (NN formula))) (CONJP (RB rather) (IN than)) (VP (VB try) (S (VP (TO to) (VP (VB make) (NP (PRP it)) (PP (IN on) (NP (PRP$ your) (JJ own))) (PP (IN from) (NP (JJ fresh) (NNS berries) (CC and) (NNS flowers))))))))))) (. .)))
89: (ROOT (S (NP (NNS Elderberries)) (VP (VBP contain) (NP (NP (JJ cyangenic) (NNS glycosides)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VP (VB be) (ADJP (JJ poisonous))) (CC and) (VP (VB cause) (NP (NN nausea) (, ,) (NN vomiting) (, ,) (NNS cramps) (, ,) (NN diarrhea) (CC and) (NN weakness))))))))) (. .)))
90: (ROOT (S (NP (JJS Most) (NN research)) (VP (VBZ has) (VP (VBN focused) (PP (IN on) (NP (NP (NP (NN elderberry) (POS 's)) (JJ therapeutic) (NN value)) (PP (IN against) (NP (NN influenza))))))) (. .)))
91: (ROOT (S (NP (NP (NNP Hadassah) (NNP University) (NNP Hospital)) (PP (IN in) (NP (NNP Israel)))) (VP (VBD found) (SBAR (IN that) (S (NP (NN elderberry)) (VP (VBD was) (ADJP (JJ effective)) (PP (IN in) (ADJP (RB vitro))) (PP (IN against) (NP (CD 10) (JJ different) (NN influenza) (NNS strains))))))) (. .)))
92: (ROOT (S (NP (NP (NN Cytokine) (NN activity)) (PP (IN for) (NP (NP (CD I-1)) (, ,) (NP (NN TN) (HYPH -) (NN a)) (, ,) (NP (CD I-6)) (CC and) (NP (CD I-8))))) (DT all) (ADVP (RB significantly)) (VP (VBD increased) (ADVP (RB thereby)) (VP (VBG confirming) (NP (PRP$ its) (ADJP (ADJP (NN ant) (HYPH -) (JJ inflammatory)) (CC and) (ADJP (JJ antiviral))) (NNS properties)))) (. .)))
93: (ROOT (S (NP (NP (DT Another) (JJ Israeli) (NN study)) (PP (PP (IN by) (NP (NP (NNP Hebrew) (NNP University)) (PP (IN in) (NP (NNP Jerusalem))))) (CC and) (VP (VBN published) (PP (IN in) (NP (NP (DT the) (NNP Journal)) (PP (IN of) (NP (NNP Internal) (NNP Medical) (NNP Research)))))))) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NP (NNS participants)) (VP (VBN enrolled) (PP (IN with) (NP (VBG existing) (NN flu) (JJ like) (NP (NNS symptoms)))))) (SBAR (WHNP (WP who)) (S (VP (VBD took) (NP (NP (CD 15) (NN ml)) (PP (IN of) (NP (NN elderberry) (NN syrup)))) (NP (NP (CD 4) (NNS times)) (NP (DT a) (NN day))))))) (VP (VBD recovered) (ADVP (ADVP (NP (CD four) (NNS days)) (RBR earlier)) (PP (IN than) (NP (NP (DT those)) (PP (IN on) (NP (NP (NNS medications)) (CC or) (NP (DT a) (NN placebo))))))))))) (. .)))
94: (ROOT (S (ADVP (RB Finally)) (, ,) (NP (NP (DT a) (ADJP (RBR more) (JJ recent)) (CD 2019) (NN study)) (PP (IN by) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Sydney)))))) (VP (VBD observed) (SBAR (IN that) (S (NP (NP (JJ certain) (NNS compounds)) (PP (IN in) (NP (NN elderberry)))) (VP (VBP inhibit) (NP (NP (NP (DT the) (NN flu) (NN virus) (POS 's)) (NN entry) (CC and) (NN replication)) (PP (IN in) (NP (JJ human) (NNS cells)))))))) (. .)))
95: (ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (NN research)) (VP (VBG showing) (NP (NP (NP (NN elderberry) (POS 's)) (JJ positive) (NN impact)) (PP (IN on) (NP (NN coronavirus) (NNS infections))))))) (. .)))
96: (ROOT (S (PP (IN In) (NP (CD 2014))) (, ,) (NP (NP (NNS researchers)) (PP (IN at) (NP (NNP Emory) (NNP University)))) (VP (VBD noted) (SBAR (IN that) (S (NP (NN elderberry) (NN extract)) (VP (VBD inhibited) (NP (NN coronavirus) (NN virility)) (PP (IN at) (NP (NP (DT the) (NN point)) (PP (IN of) (NP (NN infection))))))))) (. .)))
97: (ROOT (S (NP (DT The) (NNS scientists)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP (NN elderberry)) (VP (VBD rendered) (NP (DT the) (NN virus)) (ADJP (RB non) (JJ infectious)))))) (. .)))
98: (ROOT (S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (JJR better) (NNS studies)))) (VP (VBD came) (PP (IN out) (PP (IN of) (NP (NP (NML (NNP National) (NML (NNP Sun) (NNP Yat) (NNP Sen))) (NNP University)) (CC and) (NP (NP (DT the) (NML (NNP China) (NNP Medical) (NNP University)) (NNP Hospital)) (PP (IN in) (NP (NNP Taiwan))))))) (PP (IN in) (NP (CD 2019)))) (. .)))
99: (ROOT (S (NP (DT The) (NNS researchers)) (VP (VP (VP (VBD used) (NP (NP (DT an) (NN ethanol) (NN extract)) (PP (IN of) (NP (NNP Sambucus) (NN stem))))) (CC and) (VP (VBD observed) (NP (NP (PRP$ its) (NN potential)) (PP (IN against) (NP (NN coronavirus) (NN strain) (CD NL63)))))) (NP (NP (PRP It))) (VP (VBZ is) (ADJP (JJ important)) (S (VP (TO to) (VP (VB remember) (SBAR (IN that) (S (NP (NP (NNS deaths)) (VP (VBG being) (VP (VBN attributed) (PP (IN to) (NP (DT the) (NN coronavirus)))))) (VP (VBP are) (ADVP (ADVP (RBR more) (RB often)) (PP (IN than) (RB not))) (VP (VBN complicated) (PP (IN by) (NP (NP (NP (JJ secondary) (NNS infections)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB often)) (ADJP (JJ bacterial)))))) (PP (JJ such) (IN as) (NP (NN pneumonia)))))))))))))) (. .)))
100: (ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (PRP$ its) (JJ antiviral) (NNS properties))))) (, ,) (NP (NN elderberry)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ effective) (PP (IN against) (NP (JJ pathogenic) (NNS bacteria))))) (. .)))
101: (ROOT (S (PP (PP (IN Under) (NP (NN laboratory) (NNS conditions))) (PP (IN at) (NP (NP (NML (NNP Justus) (NNP Liebig)) (NNP University)) (PP (IN in) (NP (NNP Germany)))))) (, ,) (NP (NN elderberry)) (VP (VBD was) (VP (VBN shown) (S (VP (S (VP (TO to) (VP (VB be) (ADJP (RB very) (JJ effective) (PP (PP (IN against) (NP (NP (JJ several) (NNS bacteria)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NN pneumonia)) (PP (IN during) (NP (ADJP (NN fl) (HYPH -) (JJ like)) (NNS infections))))))))))) (, ,) (CC and) (PP (IN against) (NP (NP (NP (UCP (NP (NML (NNP Influenza) (NNP A) (CC and) (NNP B)) (NNS viruses)) (PP (IN in) (ADJP (JJ particular)))) (NNP Echinacea)) (NNP A) (JJ systematic) (NN review)) (PP (PP (IN of) (NP (DT the) (VBG existing) (NN research))) (PP (IN before) (NP (CD 2011)))) (PP (PP (IN by) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP British) (NNP Columbia))))) (CC and) (VP (VBN published) (PP (IN in) (NP (NP (DT the) (NN journal)) (NP (NNPS Pharmaceuticals))))))))))))) (, ,) (VP (VBD concluded) (: :) (`` `) (NP (NP (NP (NP (DT all) (NNS strains)) (PP (IN of) (NP (ADJP (JJ human) (CC and) (JJ avian)) (NN influenza) (NNS viruses)))) (VP (VBN tested))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS herpes) (NN simplex) (NN virus)) (, ,) (NP (JJ respiratory) (JJ syncytial) (NN virus)) (, ,) (CC and) (NP (NP (NNS rhinoviruses)) (, ,) (VBD were) (ADJP (RB very) (JJ sensitive) (PP (IN to) (NP (DT a) (JJ standardized) (NNP Echinacea) (NN purpurea) (NN preparation)))))))))))) ('' ')))
102: (ROOT (S (NP (NP (DT The) (NN species)) (NP (NNP Echinacea) (NNP purpurea))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VP (VB be) (ADJP (RBS most) (JJ effective))) (CC and) (VP (VBZ targets) (NP (DT the) (ADJP (RBS most) (JJ infectious)) (NNS pathogens))))))))) (. .)))
103: (ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBG purchasing) (NP (NN echinacea))))) (, ,) (VP (VB be) (ADJP (JJ certain) (SBAR (S (NP (PRP it)) (VP (VBZ is) (NP (DT the) (NN purpurea) (NN strain))))))) (. .)))
104: (ROOT (S (NP (NNP Echinicea)) (VP (VBZ does) (VP (VB present) (NP (NNS limitations)) (PP (VBG depending) (PP (IN upon) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (DT an) (NN infection)))))))) (. .)))
105: (ROOT (S (SBAR (IN Once) (S (NP (NP (DT a) (NN cold)) (VP (VBN caused) (PP (IN by) (NP (NP (DT any) (CD one)) (PP (IN of) (NP (NP (DT the) (JJ various) (NN cold) (NNS viruses)) (, ,) (PP (VBG including) (NP (NN coronavirus))) (, ,))))))) (ADVP (RBR more) (RB deeply)) (VP (VBZ infects) (NP (NP (DT the) (NN bronchia)) (CC and) (NP (DT the) (JJR lower) (NN lung)))))) (, ,) (NP (NN echinacea)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ helpful))))))) (. .)))
106: (ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (RBR more) (JJ effective) (PP (IN with) (NP (NML (JJ upper) (JJ respiratory) (NN tract)) (NNS infections))))) (. .)))
107: (ROOT (S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (JJS largest) (NN placebo) (ADJP (JJ double) (JJ blind)) (NNS studies)) (PP (IN on) (NP (NN echinacea)))))) (VP (VBD was) (VP (VBN conducted) (PP (IN by) (NP (NP (NNP Cardifff) (NNP University)) (PP (IN in) (NP (DT the) (NNP UK))))))) (. .)))
108: (ROOT (S (NP (DT The) (NN study)) (VP (VP (VBD followed) (NP (NNS participants)) (PP (IN for) (NP (CD four) (NNS months)))) (CC and) (VP (VBD confirmed) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (NML (JJ long) (NN term)) (NN echinacea) (NN supplementation)))))) (. .)))
109: (ROOT (S (NP (PRP It)) (ADVP (RB also)) (VP (VBD observed) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN decrease)) (PP (IN in) (NP (JJ cold) (NNS episodes))) (PP (IN in) (NP (DT the) (NN echinacea) (NN group))))) (. .)))
110: (ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ strong) (NNS studies)) (VP (VBG showing) (NP (NP (NP (NN echinacea) (POS 's)) (NN effectiveness)) (PP (IN against) (NP (NN coronavirus))))))) (. .)))
111: (ROOT (S (S (PP (IN Up) (PP (IN until) (NP (CD 2014)))) (, ,) (S (NP (QP (RB only) (CD one)) (NN study)) (VP (VBD looked) (PP (IN at) (NP (NP (PRP$ its) (NNS bioactivities)) (PP (IN against) (NP (NN coronavirus)))))))) (CC and) (S (NP (DT that)) (VP (VBD was) (NP (NP (DT a) (NN mouse) (NN model)) (SBAR (WHNP (WDT which)) (S (VP (VBD required) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (DT the) (NN plant) (NN extract)))))))))) (. .)))
112: (ROOT (S (PP (IN In) (NP (CD 2012))) (, ,) (NP (NP (NNP Griffith) (NNP University)) (PP (IN in) (NP (NNP Australia)))) (VP (VBD undertook) (NP (CD one) (JJ notable) (NML (JJ double) (NN blind)) (NN study)) (SBAR (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NN echinacea)) (VP (VBD provided) (NP (NN protection)) (PP (IN to) (NP (NN air) (NNS travelers))))))))))) (. .)))
113: (ROOT (S (NP (DT The) (NN study)) (VP (VBD concluded) (: :) (`` `) (S (NP (NP (NN Supplementation)) (PP (IN with) (NP (JJ standardized) (NNP Echinacea) (NNS tablets)))) (, ,) (SBAR (IN if) (S (VP (VBN taken) (PP (IN before) (CC and) (IN during) (NP (NN travel)))))) (, ,) (VP (MD may) (VP (VB have) (NP (NP (JJ preventive) (NNS effects)) (PP (IN against) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ respiratory) (NNS symptoms))) (PP (IN during) (NP (NP (NN travel)) (VP (VBG involving) (NP (NML (JJ lon) (HYPH -) (NN haul)) (NNS flights)))))))))))) (. .) ('' ')))
114: (ROOT (S (PP (IN As) (NP (NP (DT a) (NN piece)) (PP (IN of) (NP (NN consumer) (NN advice))))) (, ,) (NP (DT a) (NML (NNP Cornell) (NNP University)) (NN study)) (VP (VBD looked) (PP (IN at) (NP (NP (NP (DT the) (JJ medicinal) (NNS properties)) (PP (IN throughout) (NP (NP (JJ different) (NNS parts)) (PP (IN of) (NP (DT the) (NN echinicea) (NN plant)))))) (: :) (NP (NNS leaves) (, ,) (NP (NNS stems)) (, ,) (NN bark) (, ,) (NNS roots) (, ,) (FW et))))) (. ..)))
115: (ROOT (S (NP (DT The) (NNS scientists)) (VP (VBD noted) (SBAR (IN that) (S (NP (NP (JJ only) (NN echinacea) (NNS extracts)) (SBAR (WHNP (WDT that)) (S (VP (VBP contain) (NP (DT the) (NN root)))))) (VP (VBD showed) (NP (JJ significant) (JJ antiviral) (NNS properties)))))) (. .)))
116: (ROOT (S (NP (NN Echinacea)) (VP (VBZ appears) (S (VP (TO to) (VP (VB modify) (NP (NP (DT the) (JJ clinical) (NN course)) (PP (IN of) (NP (ADJP (NN fl) (HYPH -) (JJ like)) (JJ respiratory) (NN infection)))) (PP (IN by) (S (VP (VBG acting) (PP (IN upon) (NP (NML (CD I-8)) (, ,) (HYPH I-10) (CC and) (NML (NML (NNP IFN)) (NN cytokine)) (NN activity))) (ADVP (RB beneficially))))))))) (. .)))
117: (ROOT (S (NP (NML (NNP Olive) (NNP Leaf)) (NNP Oleuropein)) (VP (VBZ is) (NP (NP (NP (DT the) (ADJP (RBS most) (JJ important)) (NN biomolecule)) (PP (IN in) (NP (DT the) (NN olive) (NN tree)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ contributes) (PP (IN to) (NP (PRP$ its) (ADJP (NN antioxidant) (, ,) (ADJP (NN ant) (HYPH -) (JJ inflammatory)) (, ,) (ADJP (NN ant) (HYPH -) (JJ atherogenic)) (, ,) (NML (NN ant) (HYPH -) (NN cancer)) (, ,) (JJ antimicrobial) (CC and) (JJ antiviral)) (NNS activities) (CC and) (NNS effects)))))))) (. .)))
118: (ROOT (S (NP (NP (CD One) (NN advantage)) (PP (IN of) (NP (NN olive) (NN leaf)))) (VP (VBZ is) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADJP (RB highly) (JJ bioavailable) (PP (IN to) (NP (NP (DT the) (NN body) (POS 's)) (NNS cells)))))))) (. .)))
119: (ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (NP (QP (RB almost) (CD 1,000)) (NNS studies)) (PP (IN in) (NP (DT the) (NML (NML (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health)))) (NN literature) (NN database)))) (VP (VBG referring) (PP (IN to) (NP (NP (NNP OLE)) (, ,) (NP (NN olive) (NN leaf)) (, ,) (CC and) (NP (NN olive) (NN oil)))) (, ,) (PP (ADVP (RBS most)) (PP (IN with) (NP (NP (NN respect)) (PP (IN to) (NP (PRP$ its) (JJ strong) (ADJP (NN antioxidant) (CC and) (JJ anticancer)) (NNS properties))))))))) (. .)))
120: (ROOT (S (PP (VBG According) (PP (IN to) (NP (NP (NN analysis)) (VP (VP (VBN conducted) (PP (IN by) (NP (NP (DT the) (NML (NNP Regina) (NNP Elena)) (NNP National) (NNP Cancer) (NNP Institute)) (PP (IN in) (NP (NNP Rome)))))) (PP (IN of) (NP (NP (DT the) (NN oleuropein) (NN content)) (PP (IN in) (NP (NP (JJ different) (NNS parts)) (PP (IN of) (NP (DT the) (NN olive) (NN plant))))))))))) (, ,) (NP (NP (NNS extracts)) (VP (VBN made) (PP (IN from) (NP (NNS buds) (CC and) (NNS flowers))))) (VP (VBD showed) (NP (DT the) (JJS greatest) (NN strength) (CC and) (NN potency))) (. .)))
121: (ROOT (S (S (NP (NN Olive) (NN leaf)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (RB particularly) (JJ effective) (PP (IN against) (NP (JJ viral) (NML (JJ upper) (JJ respiratory)) (NNS infections))))))))))) (: ;) (S (ADVP (RB however)) (NP (EX there)) (VP (VBZ is) (NP (NP (JJ considerable) (NN evidence)) (SBAR (S (VP (TO to) (VP (VB support) (NP (NP (NN olive) (NN leaf) (POS 's)) (NN ability) (S (VP (TO to) (VP (VB strengthen) (NP (DT the) (JJ immune) (NN system)) (PP (IN against) (NP (JJ other) (JJ infectious) (JJ viral) (NNS diseases))) (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (S (VP (VBG possessing) (NP (JJ many) (ADJP (NN ant) (HYPH -) (JJ inflammatory)) (NNS qualities)))))))))))))))))) (. .)))
122: (ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (QP (RB only) (DT a) (JJ few)) (NNS studies)) (VP (VBG showing) (NP (NP (NP (NN olive) (NN leaf) (POS 's)) (NN effectiveness)) (PP (IN against) (NP (JJ respiratory) (NNS viruses))))))) (. .)))
123: (ROOT (S (NP (NP (CD One) (VBN randomized) (NN trial)) (VP (VBN performed) (PP (IN by) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Auckland))) (PP (IN in) (NP (NNP New) (NNP Zealand))))))) (VP (VBZ suggests) (SBAR (S (NP (NN olive) (NN leaf)) (VP (MD can) (VP (VB contribute) (PP (IN to) (S (VP (VBG treating) (NP (NP (JJ respiratory) (NNS illnesses)) (, ,) (PP (VBG including) (NP (NN coronavirus)))))))))))) (. .)))
124: (ROOT (S (NP (NP (DT A) (CD 2001) (NN study)) (PP (IN out) (PP (IN of) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Hong) (NNP Kong))))))) (VP (VBD identified) (NP (NP (NP (CD 6) (JJ separate) (JJ antiviral) (NNS agents)) (PP (IN in) (NP (NNS olives)))) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ effective) (PP (IN against) (NP (NP (NN parainfluenza)) (CC and) (NP (JJ respiratory) (JJ syncytial) (NN virus)))))))))) (. .)))
125: (ROOT (S (NP (NN Olive) (NN leaf)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ effective) (PP (IN against) (NP (JJ bacterial) (NNS pathogens))))) (. .)))
126: (ROOT (S (NP (JJS Most) (JJ bacterial) (NNS pneumonias)) (VP (VBP are) (ADJP (NN gra) (HYPH -) (JJ positive))) (. .)))
127: (ROOT (S (PP (VBG According) (PP (IN to) (NP (NP (DT a) (JJ joint) (NN study)) (PP (IN by) (NP (NP (ADJP (NNP Arab) (NNP American)) (NNP University)) (CC and) (NP (NP (NP (DT the) (NML (NNP University))) (PP (IN of) (NP (NNP Central) (NNP Florida))) (NNP College)) (PP (IN of) (NP (NNP Medicine))))))))) (, ,) (S (NP (NNP OLE)) (VP (VBD worked) (ADVP (RBS best)) (PP (IN against) (NP (ADJP (NN gra) (HYPH -) (JJ positive)) (NNS pathogens))))) (CC but) (S (NP (ADJP (NN gra) (HYPH -) (JJ negative)) (NNS organisms)) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (JJ resistant) (PP (IN to) (NP (NNP OLE))))))))) (. .)))
128: (ROOT (S (CC But) (NP (NNP OLE)) (VP (VBZ does) (VP (VB possess) (NP (JJ notable) (NML (NN ant) (HYPH -) (JJ viral)) (NNS properties)))) (. .)))
129: (ROOT (S (NP (DT The) (JJ current) (CD Cov19) (NN pandemic)) (VP (VBZ appears) (S (VP (TO to) (VP (VB utilize) (NP (NP (DT the) (NN host) (NN cell) (POS 's)) (CD ACE2) (NN receptor)))))) (. .)))
130: (ROOT (S (NP (DT This) (JJ same) (NN receptor)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN activated) (PP (IN in) (NP (NNP HIV) (NNS infections))))) (. .)))
131: (ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (CD one) (NN reason)) (SBAR (WHADVP (WRB why)) (S (NP (NP (NNS patients)) (VP (VBN infected) (PP (IN with) (NP (DT this) (JJ new) (NN coronavirus) (NN strain))))) (VP (VBP are) (VP (VBG being) (VP (VBN prescribed) (NP (NNP HIV) (NNS drugs))))))))) (. .)))
132: (ROOT (SQ (ADVP (RB Therefore)) (MD might) (NP (NML (JJ olive) (NN leaf)) (NN extract)) (VP (VB contribute) (PP (IN to) (NP (NP (DT the) (NN treatment)) (PP (IN for) (NP (DT this) (JJ new) (NN coronavirus) (NN strain)))))) (. ?)))
133: (ROOT (S (NP (NML (NML (NNP New) (NNP York)) (NNP University)) (NNS biochemists)) (VP (VBD identified) (NP (NP (NP (NML (NN olive) (NN leaf)) (NN extract) (POS 's)) (NML (NN ant) (HYPH -) (NN HIV)) (NN activity)) (SBAR (S (VP (TO to) (VP (VB modulate) (NP (DT the) (NML (NN host) (NN cell)) (NN gene) (NN expression)) (PP (IN due) (IN to) (NP (NNP HIV) (NN infection))))))))) (. .)))
134: (ROOT (S (PP (IN In) (NP (NN fact))) (, ,) (NP (NML (JJ olive) (NN leaf)) (NNS extracts)) (VP (VBD reversed) (NP (HYPH HI-1) (NNS infections))) (. .)))
135: (ROOT (S (NP (DT This)) (VP (VBD was) (VP (VBN published) (PP (IN in) (NP (NP (NNP Journal)) (PP (IN of) (NP (ADJP (NNP Biochemical) (CC and) (JJ Biophysical)) (NNP Research))))))) (. .)))
136: (ROOT (S (NP (DT The) (NNS conclusions)) (VP (VBP state) (, ,) (`` `) (S (NP (NP (NN Treatment)) (PP (IN with) (NP (NNP OLE)))) (VP (VBZ reverses) (NP (NP (JJ many)) (PP (IN of) (NP (DT these) (ADJP (CD HI-1) (ADJP (NN infectio) (HYPH -) (VBN associated))) (NNS changes))))))) (. .) ('' ')))
137: (ROOT (S (NP (NP (DT Another) (JJ joint) (NN study)) (PP (IN by) (NP (NP (NNP NYU)) (CC and) (NP (NNP Harvard) (NNP Medical) (NNP School))))) (VP (VBD concluded) (SBAR (IN that) (S (NP (NP (NNP OLE)) (PP (IN from) (NP (NN olive) (NN leaf)))) (VP (VP (VBZ is) (`` `) (NP (NP (DT a) (JJ unique) (NN class)) (PP (IN of) (NP (HYPH HI-1) (NNS inhibitors)))) (-RRB- ')) (CC and) (VP (VBZ is) (`` `) (ADJP (JJ effective) (PP (IN against) (NP (JJ viral) (NN fusion) (CC and) (NN integration))))))))) (. .) ('' ')))
138: (ROOT (S (NP (NNP Oregano) (NNP Oil) (NNP Oregano)) (VP (VBZ possesses) (NP (NP (NP (DT a) (NN compound)) (VP (VBN called) (S (NP (NN carvacrol))))) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ antiviral)))))))))))) (. .)))
139: (ROOT (S (SBAR (IN Although) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN tested) (PP (IN on) (NP (JJ several) (NML (UCP (NML (NN influenza)) (CC and) (ADJP (NN fl) (HYPH -) (JJ like))) (JJ respiratory) (NNS viruses))))))))) (, ,) (NP (PRP it)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB have) (VP (VBN been) (VP (VBN tested) (PP (IN against) (NP (NN coronavirus)))))))))) (. .)))
140: (ROOT (S (NP (NP (NP (NNP Soochow) (NNP University)) (PP (IN in) (NP (NNP China)))) (CC and) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Oklahoma))))) (VP (VBD published) (NP (NP (NP (DT a) (NN study)) (PP (IN in) (NP (NP (DT the) (NNP BMC) (NNP Journal)) (PP (IN of) (NP (ADJP (NNP Complementary) (CC and) (NNP Alternative)) (NNP Medicine)))))) (VP (VBG focusing) (PP (IN on) (NP (NP (NP (NNP oregano) (POS 's)) (JJ antiviral) (NNS properties)) (PP (IN against) (NP (NN influenza) (NNS viruses)))))))) (. .)))
141: (ROOT (S (SBAR (IN Although) (S (NP (NN oregano)) (VP (VBD did) (RB not) (VP (VB kill) (NP (DT the) (NN virus)))))) (NP (PRP it)) (ADVP (RB nevertheless)) (VP (VBD inhibited) (NP (NP (DT the) (NN virus) (POS ')) (NN ability) (S (VP (TO to) (VP (VB translate) (NP (NP (NNS proteins)) (ADJP (JJ responsible) (PP (IN for) (NP (DT the) (JJ viral) (NN binding))))) (PP (IN to) (NP (NNS cells)))))))) (. .)))
142: (ROOT (S (NP (NP (NP (DT A) (NML (NML (NNP University)) (PP (IN of) (NP (NNP Putra) (NNP Malaysia))))) (VBN met) (HYPH -) (NN analysis)) (PP (IN of) (NP (NP (VBG existing) (NN research)) (PP (IN of) (NP (JJ different) (NN plant) (JJ essential) (NNS oils)))))) (VP (VBD reported) (SBAR (S (NP (NN oregano)) (VP (VBD was) (ADJP (JJS strongest) (PP (IN against) (NP (DT the) (ADJP (NN fl) (HYPH -) (JJ like)) (NNS viruses) (NML (NN adenovirus) (CC and) (NML (NN coxsackie) (NN virus)))))))))) (. .)))
143: (ROOT (S (NP (NP (DT A) (CD 2010) (VBN randomized) (NML (JJ double) (JJ blind)) (NN study) (NN study)) (VP (VBN published) (PP (IN in) (NP (ADJP (ADJP (NNP Evidence) (NNP Based)) (NML (NNP Complementary) (CC and) (NNP Alternative))) (NNP Medicine))))) (VP (VBD suggested) (SBAR (S (NP (NN oregano)) (VP (VP (VBD was) (ADJP (JJ beneficial) (PP (IN as) (NP (DT a) (NN throat) (NN spray))))) (CC and) (VP (VBD showed) (NP (NP (ADJP (JJ significant) (CC and) (JJ immediate)) (NN improvement)) (PP (IN of) (NP (NML (JJ upper) (JJ respiratory)) (JJ infectious) (NNS ailments))))))))) (. .)))
144: (ROOT (S (NP (NP (NNP University)) (PP (IN of) (NP (NNP Arizona)))) (VP (VBD published) (NP (NP (NP (DT a) (NN paper)) (PP (IN in) (NP (NP (DT the) (NNP Journal)) (PP (IN of) (NP (NNP Applied) (NNP Microbiology)))))) (VP (VBG investigating) (NP (NP (NP (NN oregano) (POS 's)) (JJ antiviral) (NNS properties)) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN as) (NP (DT a) (NN sanitizer)))))))))) (. .)))
145: (ROOT (S (NP (DT The) (NN study)) (VP (VBD focused) (PP (IN on) (NP (NP (CD one) (ADJP (NN fl) (HYPH -) (JJ like)) (NN virus)) (, ,) (NP (NN novovirus))))) (. .)))
146: (ROOT (S (SBAR (IN If) (S (VP (VBN sprayed) (PP (IN on) (NP (NNS surfaces)))))) (, ,) (NP (NN carvacrol)) (VP (MD will) (VP (VB kill) (NP (DT the) (NN virus)) (PP (IN within) (NP (NP (CD 15) (NNS minutes)) (PP (IN of) (NP (NN exposure))))))) (. .)))
147: (ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ recent)) (NN research)) (PP (IN into) (NP (NP (NP (NNP Cov19) (POS 's)) (NN surface) (NN life)) (: -) (S (VP (VBG living) (ADVP (IN outside) (PP (IN of) (NP (NN animal) (NN host)))))) (: -)))) (VP (VBZ is) (NP (CD 9) (NNS days))) (. .)))
148: (ROOT (S (NP (NML (JJ Other) (NNPS Botanicals)) (NP (NNPS Saikosaponins))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN family)) (PP (IN of) (NP (NP (NNS compounds)) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NNP Bupleurum) (NN plant)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (JJ possible) (NML (NN ant) (HYPH -) (NN coronavirus)) (NNS properties))))))))))))))))) (. .)))
149: (ROOT (S (NP (NP (NNP Kaohsiung) (NNP Medical) (NNP University)) (PP (IN in) (NP (NNP Taiwan)))) (VP (VP (VBD examined) (NP (NP (JJ many)) (PP (IN of) (NP (NP (DT the) (NNS derivatives)) (PP (IN of) (NP (NNS saikosaponins))))))) (CC and) (VP (VBD observed) (SBAR (S (NP (PRP it)) (VP (VBZ has) (NP (NP (ADJP (RB very) (JJ potent)) (NML (NN ant) (HYPH -) (JJ coronaviral)) (NN activity)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interferes) (PP (IN with) (NP (NP (DT the) (JJ early) (NN stage)) (PP (IN of) (NP (NP (DT the) (NN virus) (POS ')) (NN replication)))))))))))))) (. .)))
150: (ROOT (S (S (NP (JJ Several) (NNS companies)) (VP (VBP offer) (NP (NNP Bupleurum)) (ADVP (RB online)) (NP (NP (NNP University) (NNP College)) (NNP Dublin)))) (CC and) (S (NP (NNP Sichuan) (NNP Agricultural) (NNP University)) (VP (VBD conducted) (NP (NP (DT a) (JJ systematic) (VBN met) (HYPH -) (NN review)) (PP (IN of) (NP (NP (DT the) (VBG existing) (JJ medical) (NN literature)) (PP (IN on) (NP (NP (JJ Chinese) (NNS herbs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB prevent) (CC and) (VB treat) (NP (JJ viral) (JJ respiratory) (NNS infections))))))))))))) (. .)))
151: (ROOT (SINV (PP (IN Among) (NP (NP (DT the) (ADJP (RBS most) (JJ promising)) (NNS herbs)) (PP (IN against) (NP (NNP SARS) (NN coronavirus))))) (VP (VBD were)) (NP (NP (NN panax) (NN ginseng)) (, ,) (NP (NP (NN glycyrrhizin)) (PP (IN from) (NP (NN licorice)))) (, ,) (CC and) (NP (NP (NN Isatis) (NN tinctoria)) (, ,) (VP (ADVP (RB commonly)) (VBN known) (PP (IN as) (NP (NP (NN woad) (CC or) (NNP Asp)) (PP (IN of) (NP (NNP Jerusalem)))))))) (. .)))
152: (ROOT (S (NP (NNP Isatis)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ available)) (ADVP (RB online))) (. .)))
153: (ROOT (S (NP (NP (FW Houttuynia) (NNP cordata)) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NP (NN fish) (NN mint)) (, ,) (NP (NN rainbow) (NN plant)) (, ,) (NP (NN fish) (NN wort)) (, ,) (NP (NP (NN bishop) (POS 's)) (NN weed)))))) (VP (VBZ is) (ADJP (JJ indigenous) (PP (IN to) (NP (NNP Southeast) (NNP Asia))))) (. .)))
154: (ROOT (S (NP (DT This) (NN botanical)) (ADVP (RB directly)) (VP (VP (VBZ inhibits) (NP (NP (NN coronavirus) (POS ')) (NN protease))) (CC and) (VP (VBZ blocks) (NP (DT the) (JJ viral) (NML (NN RNA) (NN polymerase)) (NN activity)))) (. .)))
155: (ROOT (S (NP (NP (DT A) (NN study)) (PP (IN out) (PP (IN of) (NP (NP (NNP Tsinghua) (NNP University)) (PP (IN in) (NP (NNP Beijing))))))) (VP (VBD found) (SBAR (S (NP (PRP it)) (ADVP (RB significantly)) (VP (VBZ reduces) (NP (NP (NP (NNS fevers)) (, ,) (NP (JJ sore) (NN throat)) (CC and) (NNS coughs)) (PP (IN due) (IN to) (NP (DT the) (NNP SARS) (NN virus)))))))) (. .)))
156: (ROOT (S (NP (NP (NNS Tinctures)) (PP (IN of) (NP (DT this) (NN plant)))) (VP (VBP are) (ADJP (JJ available)) (ADVP (RB online))) (. .)))
157: (ROOT (NP (NP (NNS SUPPLEMENTS)) (: :) (S (NP (S (NP (NNP Vitamin) (NNP C)) (PP (IN Unlike) (NP (DT the) (NNP US)))) (, ,) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NN world))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (NP (NNP Asia)) (CC and) (NP (JJ continental) (NNP Europe)))) (, ,))) (VP (VBZ recognizes) (NP (NNP Vitamin) (NNP C)) (PP (IN as) (NP (DT an) (JJ important) (NML (NN ant) (HYPH -) (NN viral)) (NN agent))))) (. .)))
158: (ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (JJ remarkable) (NN antioxidant)) (VP (VBN shown) (S (VP (TO to) (VP (VB ward) (PRT (RP off)) (NP (NNS infections)))))))) (. .)))
159: (ROOT (S (PP (IN At) (NP (DT this) (NN moment))) (, ,) (NP (NNP China)) (VP (VBZ is) (VP (VBG conducting) (NP (NP (NP (JJ several) (JJ clinical) (NNS trials)) (PP (IN with) (NP (JJ intravenous) (NNP Vitamin) (NNP C)))) (SBAR (S (VP (TO to) (VP (VB treat) (NP (NP (NNS patients)) (VP (VBN infected) (PP (IN with) (NP (DT the) (CD Cov19) (NN strain)))))))))))) (. .)))
160: (ROOT (S (NP (NP (DT The) (NN city) (NN government)) (PP (IN of) (NP (NNP Shanghai)))) (VBZ is) (ADVP (RB now)) (ADVP (RB actively)) (VBG treating) (NP (NNS patients)) (IN with) (JJ intravenous) (NNP Vitamin) (. C.)))
161: (ROOT (S (NP (NP (DT A) (NN trial)) (PP (IN at) (NP (NP (NNP Zhongnan) (NNP Hospital)) (PP (IN in) (NP (NNP Wuhan)))))) (VP (VBZ is) (VP (VBG using) (NP (NP (CD 2,000) (NNS mg)) (PP (IN per) (NP (NN day)))) (ADVP (RB intravenously)))) (. .)))
162: (ROOT (S (NP (DT The) (NNP Wuhan) (NN study)) (VP (MD can) (VP (VB be) (VP (VBN viewed) (PP (PP (PP (IN on) (NP (NP (NP (NP (DT the) (NNP US) (NNP National) (NNP Library)) (PP (IN of) (NP (NNP Medicine))) (POS 's)) (NN website)) (ADVP (RB here)))) (: :) (NP (NP (NNP http:/clinicaltrial.go) (HYPH /) (NNP ct) (SYM /) (NN sho) (SYM /) (CD NCT04264533)) (PP (IN Until) (ADVP (RB recently))))) (, ,) (NP (NNP Vitamin) (NNP C)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN tested) (PP (IN against) (NP (NN coronavirus)))))))))) (. .)))
163: (ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (CD one) (NN study)) (VP (VBN performed) (S (VP (TO to) (VP (VB see) (SBAR (IN whether) (S (NP (DT the) (NN vitamin)) (VP (VBD protected) (NP (NML (NN chick) (NN embryo)) (NNS organs)) (PP (IN from) (NP (NP (NN infection)) (PP (IN by) (NP (NP (JJ avian) (NN coronavirus)) (: -) (NP (NP (DT a) (ADJP (RB very) (JJ common)) (NN infection)) (PP (IN in) (NP (NN fowl))))))))))))))))) (. .)))
164: (ROOT (S (NP (DT That) (NN study)) (VP (VBD showed) (SBAR (S (NP (DT the) (NN vitamin)) (ADVP (RB positively)) (VP (VBD increased) (NP (NP (NN embryo) (NN resistance)) (PP (IN against) (NP (DT the) (NN virus)))))))) (. .)))
165: (ROOT (S (ADVP (RB Otherwise)) (, ,) (NP (NNP Vitamin) (NNP C)) (VP (VBZ has) (ADVP (RB only)) (VP (VBN been) (ADVP (RB well)) (VP (VBN studied) (PP (IN against) (NP (NP (JJ other) (JJ viral) (NNS infections)) (, ,) (NP (ADVP (RB especially)) (NN influenza))))))) (. .)))
166: (ROOT (S (NP (NP (NNP Seoul) (NML (NNP National) (NNP University)) (NNP College)) (PP (IN of) (NP (NNP Medicine)))) (VP (VBD concluded) (SBAR (IN that) (S (NP (NNP Vitamin) (NNP C)) (VP (VBZ is) (NP (NP (DT an) (JJ essential) (NN factor)) (PP (IN for) (NP (ADJP (NN ant) (HYPH -) (JJ viral)) (JJ immune) (NNS responses)))) (PP (IN at) (NP (NP (DT the) (JJ early) (NN stage)) (PP (IN of) (NP (NML (NNP Influenza) (NNP A)) (NN infection))))))))) (. .)))
167: (ROOT (S (PP (IN In) (NP (CD 2017))) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Helsinki)))) (VP (VBD reviewed) (NP (NP (CD 148) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (VBD indicated) (SBAR (S (NP (NNP Vitamin) (NNP C)) (VP (MD may) (VP (VB alleviate) (CC or) (VB prevent) (NP (NP (NNS infections)) (VP (VBN caused) (PP (IN by) (NP (NNS bacteria) (CC and) (NNS viruses)))))))))))))) (. .)))
168: (ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ extensive)) (NN indication)) (VP (VBN studied))) (VP (VBD was) (NP (DT the) (JJ common) (NN cold))) (. .)))
169: (ROOT (S (PP (IN Among) (NP (NP (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADJP (RB physically) (JJ active))))))) (, ,) (NP (NNP Vitamin) (NNP C)) (VP (VBD was) (ADJP (RBS most) (JJ beneficial))) (. .)))
170: (ROOT (S (ADVP (RB However)) (, ,) (NP (JJ many) (NNS studies)) (VP (VBD relied) (PP (IN on) (NP (NP (ADJP (RB very) (JJ low)) (NML (NNP Vitamin) (NNP C)) (NNS doses)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB likely)) (VP (VBD contributed) (PP (IN to) (NP (NP (DT the) (JJ minor) (NNS benefits)) (VP (VBN observed)))))))))) (. .)))
171: (ROOT (S (NP (NP (DT Some)) (PP (IN of) (NP (DT these)))) (VP (VBD were) (ADJP (ADJP (RB as) (JJ low)) (PP (IN as) (NP (NP (CD 100) (NN mg)) (ADVP (RB daily)))))) (. .)))
172: (ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NNS studies)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NNS colds) (POS ')) (NN duration)) (VP (VBD was) (ADJP (ADVP (RB frequently)) (ADJP (ADJP (JJR shorter)) (CC and) (ADJP (RBR less) (JJ severe)))) (PP (IN among) (NP (NP (NNS people)) (PP (IN with) (NP (JJ sufficient) (NML (NNP Vitamin) (NNP C)) (NNS levels))))))))) (. .)))
173: (ROOT (S (NP (NP (DT An) (JJ early) (VBN randomized) (NML (JJ double) (JJ blind)) (NN trial)) (SBAR (S (VP (TO to) (VP (VB investigate) (NP (NP (NNP Vitamin) (NNP C) (POS 's)) (NN ability) (S (VP (TO to) (VP (VB protect) (NP (JJ elderly) (VBN hospitalized) (NNS patients)) (PP (IN from) (NP (JJ acute) (JJ respiratory) (NNS infections)))))))))))) (VP (VBD was) (VP (VBN conducted) (PP (IN at) (NP (NP (NNP Hudderfield) (NNP University)) (PP (IN in) (NP (DT the) (NNP UK))))))) (. .)))
174: (ROOT (S (NP (DT The) (NN study)) (VP (VBD relied) (PP (IN on) (NP (NP (DT a) (ADJP (RB very) (JJ low)) (NN dose)) (PP (IN of) (NP (NP (CD 200) (NNS mg)) (PP (IN per) (NP (NN day)))))))) (. .)))
175: (ROOT (S (ADVP (RB Nevertheless)) (, ,) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (DT the) (NN vitamin)))))) (VP (VBD faired) (ADVP (ADVP (RB significantly) (RBR better)) (PP (IN than) (NP (NP (DT those)) (VP (VBG taking) (NP (NN placebo))))))) (. .)))
176: (ROOT (S (ADVP (RB Finally)) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT another) (JJ early) (VBN controlled) (NN placebo) (NN study)) (VP (VBG involving) (NP (NP (NP (CD 715) (NNS students)) (PP (IN between) (NP (NP (DT the) (NNS ages)) (PP (SYM 1) (HYPH -) (CD 32))))) (VP (VBG taking) (NP (CD 1000) (NNS mg)) (ADVP (NP (CD four) (NNS times)) (ADVP (RB daily)))))))) (. .)))
177: (ROOT (S (NP (DT The) (NN test) (NN group)) (VP (VBD had) (NP (NP (DT an) (NML (CD 85) (NN %)) (NN decrease)) (PP (IN in) (NP (NML (NN flu) (CC and) (JJ cold)) (NNS symptoms)))) (PP (VBN compared) (PP (IN to) (NP (DT the) (NN control))))) (. .)))
178: (ROOT (S (NP (NP (NN Vitamin) (NNP D)) (NP (QP (RB Barely) (DT a)) (NN week))) (VP (VBZ goes) (ADVP (RB by)) (PP (IN without) (NP (NP (NP (DT another) (NN study)) (VP (VBG appearing) (PP (IN in) (NP (DT the) (ADJP (NN pee) (HYPH -) (VBN reviewed)) (NN literature))))) (SBAR (WHNP (WDT that)) (S (VP (VBZ looks) (PP (IN at) (NP (DT either) (NP (NP (NNP Vitamin) (NNP D) (POS 's)) (JJ therapeutic) (NNS characteristics)) (CC or) (NP (NP (DT the) (NNS risks)) (PP (IN of) (NP (NML (NNP Vitamin) (NNP D)) (NN deficiency)))))))))))) (. .)))
179: (ROOT (S (NP (NP (DT A) (JJ high) (NN number)) (PP (IN of) (NP (ADJP (RB otherwise) (JJ healthy)) (NNS adults)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB have) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NN vitamin) (NN D)))) (, ,) (PP (ADVP (RB mostly)) (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NNP Winter) (NN season))))))))))) (. .)))
180: (ROOT (S (NP (NN Deficiency) (NNS rates)) (VP (VBP vary) (PP (IN between) (NP (NP (CD 42) (NN %)) (PP (IN for) (NP (DT the) (JJ entire) (NN population))) (PP (IN to) (NP (NP (NP (CD 82) (NN %)) (PP (IN for) (NP (NNP Black) (NNPS Americans)))) (CC and) (NP (NP (CD 63) (NN %)) (PP (IN for) (NP (NNPS Latinos))))))))) (. .)))
181: (ROOT (S (NP (NP (NNS People)) (SBAR (WHNP (WP who)) (S (VP (S (VP (VBP are) (ADJP (JJ housebound)))) (, ,) (ADJP (VBN institutionalized)) (CC and) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP work) (NP (NN night) (NNS shifts)))))))))) (VP (VBP are) (ADJP (RBS most) (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (NP (NN vitamin) (NN D)) (JJ deficient))))))) (. .)))
182: (ROOT (S (NP (DT This)) (VP (VBZ includes) (NP (NP (JJ many) (JJ elderly) (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VBP receive) (NP (NP (JJ limited) (NN exposure)) (PP (IN to) (NP (NN sunlight))))))))) (. .)))
183: (ROOT (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NML (NNP Vitamin) (NNP D)) (NN deficiency)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT an) (NN increase) (NN risk)) (PP (IN in) (NP (NN autoimmunity) (NNS illnesses)))) (CC and) (NP (NP (JJR greater) (NN susceptibility)) (PP (IN to) (NP (NN infection))))))))))))) (. .)))
184: (ROOT (S (NP (PRP It)) (ADVP (RB also)) (VP (VBZ boosts) (PRT (RP up)) (NP (NP (DT the) (NN body) (POS 's)) (JJ mucosal) (NNS defenses)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (ADJP (JJ critical) (PP (IN for) (S (VP (VBG protecting) (NP (PRP ourselves)) (PP (IN from) (NP (JJ infectious) (JJ respiratory) (NNS viruses))))))) (NP (NP (NNP Harvard)) (CC and) (NP (NNP Massachusetts) (NNP General) (NNP Hospital)))) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (DT a) (JJ global) (JJ collaborative) (NN study)) (SBAR (S (VP (TO to) (VP (VB follow) (PRT (RP up)) (PP (IN on) (NP (NP (NP (DT a) (NNP Cochrane) (NN analysis)) (PP (IN of) (NP (NP (CD 25) (VBN randomized) (VBN controlled) (NNS trials)) (VP (VBG involving) (NP (CD 1,000) (NNS participants)))))) (VP (VBD confirmed) (NP (DT that) (NN vitamin))))))))))))))))) (. .)))
185: (ROOT (S (NP (DT The) (JJ Japanese) (NNS scientists)) (ADVP (RB also)) (VP (VBD observed) (SBAR (IN that) (S (NP (NP (NNS people)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN asthma)))))) (VP (VBD were) (ADVP (RBS best)) (VP (VBN protected)))))) (. .)))
186: (ROOT (S (PP (IN For) (NP (NNS children))) (, ,) (NP (DT a) (NML (NML (NNP Childrens) (NNP Hospital)) (PP (IN of) (NP (NNP Philadelphia)))) (NN meta) (NN review)) (VP (VBD identified) (NP (NP (QP (CD 13) (IN of) (CD 18)) (NNS studies)) (VP (VBG confirming) (SBAR (IN that) (S (NP (NML (NNP Vitamin) (NNP D)) (NN deficiency)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (VBN increased) (NNS incidences)) (PP (IN of) (NP (JJ acute) (JJR lower) (JJ respiratory) (NN infection)))))))))))) (. .)))
187: (ROOT (S (NP (NML (NN -Acetyl) (NN Cysteine)) (JJ Oxidative) (NN stress)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB well) (VBN known)) (NN pathway)) (PP (IN for) (NP (NP (JJ microbial) (NNS infections)) (PP (JJ such) (IN as) (NP (NP (NNS viruses)) (CC and) (NP (JJ bacterial) (NN pneumonia)))))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (DT the) (NNS lungs))))) (. .)))
188: (ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (NNS lungs)) (VP (VBP are) (ADJP (JJ subject) (PP (IN to) (NP (JJ serious) (JJ oxidative) (NN stress))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ inflammatory) (NNS cytokines)) (, ,) (NP (ADVP (RB especially)) (NP (CD I-1)) (, ,) (NP (CD I-8)) (CC and) (NP (NP (NML (NN Tumor) (NN necrosis)) (NN factor)) (CC or) (NML (NNP TNF)))))))) (. .)))
189: (ROOT (S (NP (NP (DT Each)) (PP (IN of) (NP (DT these) (NNS cytokines)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (ADVP (RB repeatedly)) (PP (IN in) (NP (JJ clinical) (NN research))) (S (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (JJ different) (JJ respiratory) (NNS infections)) (PP (VBG including) (NP (NP (NN influenza)) (, ,) (NP (NN coronavirus)) (, ,) (NP (NN echovirus)) (, ,) (NP (NN adenovirus)) (, ,) (NP (NN coxsackie) (NN virus)) (CC and) (NP (NNS others)))))))))))) (. .)))
190: (ROOT (S (ADVP (RB Therefore)) (, ,) (NP (JJ certain) (NNS antioxidants)) (VP (MD can) (VP (VB alleviate) (NP (NP (NN lung) (NN damage)) (PP (IN due) (IN to) (NP (JJ oxidative) (NN stress)))))) (. .)))
191: (ROOT (S (NP (NN -acetyl) (NN cysteine)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (ADJP (RB extremely) (JJ important)) (NNS antioxidants))))) (. .)))
192: (ROOT (S (NP (PRP It)) (VP (VBZ exhibits) (NP (ADJP (CC both) (JJ direct) (CC and) (JJ indirect)) (NN antioxidant) (NNS properties))) (. .)))
193: (ROOT (S (NP (DT The) (JJ indirect) (NN benefit)) (VP (VBZ is) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ increases) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (DT another) (JJ important) (NN antioxidant)) (, ,) (NP (NN glutathione)) (, ,))) (PP (IN in) (NP (DT the) (NN lung) (NNS cells)))))))) (. .)))
194: (ROOT (S (S (NP (EX There)) (VP (VBZ is) (NP (DT no) (JJ confirmatory) (NN evidence) (SBAR (IN that) (S (NP (NNP NAC)) (ADVP (RB directly)) (VP (VBZ targets) (NP (ADJP (NN flu) (CC or) (NN fl) (HYPH -) (JJ like)) (JJ viral) (NNS infections)))))))) (: ;) (S (ADVP (RB however)) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB reduce) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (JJ clinical) (NNS symptoms))))))))))) (. .)))
195: (ROOT (S (NP (NP (NML (NNP Johann) (NNP Goethe)) (NNP University) (NNP Department)) (PP (IN of) (NP (NNP Virology)))) (VP (VBD observed) (SBAR (IN that) (S (NP (NNP NAC)) (VP (VBZ inhibits) (NP (NP (DT the) (NN replication)) (PP (IN of) (NP (JJ seasonal) (JJ human) (NN influenza) (NNP A) (NNS viruses)))) (PP (IN by) (S (VP (VBG decreasing) (NP (JJ several) (DT these) (ADJP (NN pr) (HYPH -) (JJ inflammatory)) (NNS molecules))))))))) (. .)))
196: (ROOT (S (NP (DT The) (NNS scientists)) (VP (VBP recommend) (SBAR (IN that) (S (NP (NNP NAC)) (VP (MD should) (VP (VB be) (VP (VBN included) (PP (IN as) (NP (DT an) (JJ additional) (NN treatment) (NN option))) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT an) (NML (NN influenza) (NNP A)) (NN pandemic))))))))))) (. .)))
197: (ROOT (S (NP (NP (DT An) (JJ Italian) (VBN randomized) (NN placebo) (NN study)) (VP (VBN conducted) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Genoa))))))) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (S (VP (VBD were) (ADVP (RB already)) (VP (VBN suspected) (PP (IN of) (S (VP (VBG having) (NP (NP (NN contact)) (PP (IN with) (NP (DT the) (CD H1N1) (NN flu) (NN virus)))))))))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN placed) (PP (IN under) (NP (NNP NAC) (NN treatment))))))))))) (VP (VBD had) (NP (NP (NP (DT a) (NML (CD 25) (NN %)) (NN rate)) (PP (IN of) (S (VP (VBG experiencing) (NP (NNS symptoms)))))) (PP (VBN compared) (PP (IN to) (NP (NP (CD 79) (NN %)) (PP (IN in) (NP (DT the) (NN placebo) (NN group))))))))))) (. .)))
198: (ROOT (S (NP (NP (JJ Certain) (NNS cytokines)) (, ,) (NP (ADVP (RB especially)) (NP (NN tumor) (NN necrosis) (NN factor)) (CC and) (NP (CD I-6))) (, ,)) (VP (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN influenza)))))))) (CC and) (VP (MD can) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN mortality))))))) (. .)))
199: (ROOT (S (PP (IN In) (NP (DT a) (NN mouse) (NN study))) (, ,) (NP (NP (JJ Italian) (NNS researchers)) (PP (IN at) (NP (NNP Zambon) (NNP Research) (NNP Center)))) (VP (VBD gave) (NP (NNP NAC)) (PP (IN to) (NP (ADJP (NN fl) (HYPH -) (VBN infected)) (NNS mice))) (PP (IN with) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NN mortality)))))) (. .)))
200: (ROOT (S (NP (NP (NML (JJ Colloidal) (NN Silver)) (NN Nanoparticle)) (CC or) (NP (JJ colloidal) (NN silver))) (VP (VBZ has) (VP (VBN been) (VP (VBN studied) (ADVP (RB extensively)) (PP (PP (IN for) (NP (PRP$ its) (ADJP (NN ant) (HYPH -) (JJ bacterial)) (NNS properties))) (CC but) (VP (ADVP (RBR less) (RB so)) (PP (IN for) (NP (JJ infectious) (NNS viruses)))))))) (. .)))
201: (ROOT (S (NP (NP (JJS Most) (NNS studies)) (PP (IN for) (NP (NP (NN silver) (POS 's)) (JJ antiviral) (NNS activities)))) (VP (VBP have) (VP (VBN focused) (PP (IN on) (NP (NP (CD HI-1)) (, ,) (NP (NNP Hepatitis) (NNP B)) (, ,) (NP (NN herpesvirus)) (CC and) (NP (NP (JJ respiratory) (JJ syncytial) (NN virus)) (CC or) (NP (NNP RSV))))))) (. .)))
202: (ROOT (S (PP (IN In) (NP (NP (DT a) (CD 2005) (NN issue)) (PP (IN of) (NP (NP (DT the) (NNP Journal)) (PP (IN of) (NP (NNP Nanotechnology))))))) (, ,) (S (NP (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Texas)))) (CC and) (NP (NNP Mexico) (NNP University))) (VP (VBD observed) (SBAR (IN that) (S (NP (JJ silver) (NNS nanoparticles)) (VP (MD could) (VP (VB kill) (NP (HYPH HI-1)) (PP (IN within) (NP (CD 3) (NNS hours))))))))) (, ,) (CC and) (S (NP (PRP they)) (VP (VBD suspected) (SBAR (IN that) (S (NP (DT this)) (VP (MD may) (VP (VB be) (ADJP (JJ true)) (PP (PP (IN for) (NP (JJ many) (JJ other) (NNS viruses))) (ADVP (RB as) (RB well))))))))) (. .)))
203: (ROOT (S (ADVP (RB However)) (, ,) (S (NP (DT this) (NN conclusion)) (VP (MD may) (VP (VB be) (ADJP (RB too) (JJ premature))))) (CC and) (S (NP (JJR more) (NN research)) (VP (VBZ is) (ADJP (JJ necessary)))) (. .)))
204: (ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (NNS studies)) (VP (VBG showing) (NP (NP (NP (NN silver) (POS 's)) (NN efficacy)) (PP (IN against) (NP (JJ respiratory) (NNS viruses))))))) (. .)))
205: (ROOT (S (NP (NP (NP (CD One) (JJ large) (NN study)) (PP (IN by) (NP (NP (NNP Japan) (POS 's)) (NML (NNP National) (NML (NNP Defense) (NNP Medical) (NNP College))) (NNP Research) (NNP Institute)))) (, ,) (VP (VBN published) (PP (IN in) (NP (NP (DT the) (NNP Journal)) (PP (IN of) (NP (NNP Molecular) (NNPS Sciences)))))) (, ,)) (VP (VBD recommended) (SBAR (IN that) (S (NP (JJ Japanese) (NN healthcare) (NNS workers)) (VP (VB take) (NP (NN nanosilver)) (S (VP (TO to) (VP (VB protect) (NP (PRP them)) (PP (IN from) (NP (NP (NNS viruses)) (PP (VBG including) (NP (NN coronavirus)))))))))))) (. .)))
206: (ROOT (S (PP (IN In) (NP (CD 2010))) (, ,) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Naples)))) (VP (VBD measured) (NP (NP (JJ silver) (NNS nanoparticles) (POS ')) (NNS capabilities) (S (VP (TO to) (VP (VB reduce) (CC and) (VB prevent) (NP (NP (NN infection)) (PP (IN from) (NP (DT the) (NN parainfluenza) (NML (NN type) (CD 3)) (NN virus))))))))) (. .)))
207: (ROOT (S (NP (DT The) (NNS scientists)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP (DT the) (NN silver)) (VP (MD may) (VP (VB block) (NP (NP (NP (DT the) (NN virus) (POS ')) (NN interaction)) (PP (IN with) (NP (DT the) (NN cell))))))))) (. .)))
208: (ROOT (S (ADVP (RB Then)) (NP (NP (DT a) (JJ joint) (NN study)) (PP (IN by) (NP (NP (NP (NNP Deakin) (NNP University)) (PP (IN in) (NP (NNP Australia)))) (CC and) (NP (NP (NNP Osaka) (NNP University)) (PP (IN in) (NP (NNP Japan))))))) (VP (VBD found) (SBAR (SBAR (IN that) (S (NP (JJ colloidal) (NN silver)) (ADVP (RB significantly)) (VP (VP (VBD protected) (NP (NNS cells)) (PP (IN from) (NP (CD H3N2) (NN flu) (NN infection)))) (CC and) (VP (VBD prevented) (NP (NP (JJ viral) (NN growth)) (PP (IN in) (NP (DT the) (NNS lungs)))))))) (ADVP (RB Finally)) (, ,) (NP (NML (JJ colliodal) (CC or) (NN nanoparticle)) (NN gold)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NP (DT the) (NN flu) (NN virus) (POS ')) (NN binding) (NN capaticity)) (PP (IN to) (NP (NP (DT a) (NN cell) (POS 's)) (NN plasma) (NN membrane)))))))))))) (. .)))
209: (ROOT (S (NP (DT That) (NN research)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN by) (NP (NP (NNP Freie) (NNP University)) (PP (IN in) (NP (NNP Germany))))))) (. .)))
210: (ROOT (NP (NN Conclusion) (: :)))
211: (ROOT (S (PP (IN At) (NP (DT the) (NN moment))) (, ,) (NP (NP (DT the) (JJ primary) (NNS solutions)) (VP (VBG being) (VP (VBN sought) (S (VP (TO to) (VP (VB handle) (NP (DT the) (NN crisis)))))))) (VP (VBZ is) (S (VP (TO to) (VP (VB spend) (NP (NP (NNS billions)) (PP (IN of) (NP (NNS dollars)))) (S (VP (TO to) (VP (VB develop) (NP (NP (DT an) (JJ effective) (NN vaccine)) (CC and) (NP (DT an) (JJ accurate) (JJ diagnostic) (NN kit)))))))))) (. .)))
212: (ROOT (S (ADVP (RB Additionally)) (, ,) (PP (VBG according) (PP (IN to) (NP (NP (DT a) (NN study)) (PP (IN out) (PP (IN of) (NP (NP (NP (NNP Johns) (NNP Hopkins) (NNP University) (POS 's)) (NNP School)) (PP (IN of) (NP (NNP Public) (NNP Health))))))))) (, ,) (NP (DT the) (NN incubation) (NN period)) (VP (VBZ is) (VP (VBN estimated) (PP (IN at) (NP (CD .1) (NNS days))) (PP (IN for) (S (VP (VBG being) (VP (VP (VBN infected)) (CC and) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG infecting) (NP (NNS others)) (PP (IN without) (S (VP (VBG displaying) (NP (NNS symptoms))))))))))))))) (. .)))
213: (ROOT (S (CC But) (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (NN mention)) (PP (IN in) (NP (NP (DT the) (JJ medical) (NN community)) (CC nor) (NP (DT the) (JJ mainstream) (NNS media)))) (PP (IN about) (SBAR (WHNP (WP what)) (S (NP (PRP we)) (VP (MD can) (VP (VB do) (S (VP (TO to) (VP (VB strengthen) (NP (PRP$ our) (JJ immune) (NN system)))))))))))) (. .)))
214: (ROOT (S (INTJ (UH Yes)) (, ,) (NP (DT a) (NML (JJ high) (NN quality)) (NML (CD 99) (NN %)) (NN barrier) (NN mask)) (VP (VBZ is) (ADJP (JJ important)) (, ,) (SBAR (ADVP (RB especially)) (IN if) (S (VP (VBN worn) (PP (IN in) (NP (DT a) (JJ crowded) (NN environment))))))) (. .)))
215: (ROOT (NP (NP (JJ Repeated) (NN washing)) (PP (IN of) (NP (PRP$ our) (NNS hands))) (PP (IN for) (NP (DT a) (JJ full) (NN minute))) (PP (IN with) (NP (NN soap) (NN water))) (. .)))
216: (ROOT (S (VP (VP (VB Rub) (NP (NNS surfaces)) (PP (IN with) (NP (NN alcohol))) (PP (IN at) (NP (NN home) (CC and) (NN work)))) (CC and) (VP (VB allow) (S (NP (PRP it)) (VP (TO to) (VP (VB sit) (PP (IN for) (NP (CD 30) (NNS seconds)))))))) (. .)))
217: (ROOT (S (ADVP (RB Likewise)) (, ,) (VP (VB wipe) (PRT (RP down)) (NP (NP (NN door) (NNS handles)) (CC and) (NP (NN telephone) (NNS receivers)))) (. .)))
218: (ROOT (S (S (VP (VBG Quarantining) (NP (NP (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (VP (VBN exposed))))))))) (VP (VBZ is) (ADJP (JJ important)) (SBAR (IN until) (S (NP (PRP they)) (VP (VBP test) (ADJP (JJ negative)))))) (. .)))
219: (ROOT (S (S (VP (VBG Closing) (NP (NNS schools)))) (VP (VBZ is) (ADJP (JJ prudent))) (. .)))
220: (ROOT (S (CC And) (SBAR (IN if) (S (NP (DT a) (NN vaccine)) (VP (VBZ is) (ADVP (RB eventually)) (VP (VP (VBN developed)) (CC and) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ safe) (CC and) (JJ effective)))))))))) (NP (DT that)) (VP (VBZ is) (NP (DT another) (NN recourse))) (. .)))
221: (ROOT (S (ADVP (RB However)) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (RB above)))) (VP (VBZ protects) (NP (DT the) (JJ immune) (NN system)) (PP (IN in) (NP (NP (DT the) (NN event)) (PP (IN of) (S (VP (VBG coming) (PP (PP (IN into) (NP (NN contact))) (PP (IN with) (NP (DT the) (NN virus)))))))))) (. .)))
222: (ROOT (S (NP (PRP We)) (VP (VBP believe) (IN that) (S (S (NP (NP (DT the) (VBN recommended) (JJ natural) (NNS solutions)) (VP (VBN shared) (ADVP (RB above)))) (, ,) (SBAR (IN since) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN supported) (PP (IN in) (NP (DT the) (ADJP (NN peer) (VBN reviewed)) (JJ scientific) (NN literature))))))) (, ,)) (VP (VBZ is) (NP (NP (NN something)) (SBAR (S (NP (NN everyone)) (VP (MD can) (VP (VB do))))))))) (. .)))
223: (ROOT (S (ADVP (RB Besides)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ safe) (CC and) (RB not) (JJ expensive))) (. .)))
224: (ROOT (S (ADVP (RB Therefore)) (NP (DT these) (JJ natural) (NNS solutions)) (ADVP (RB too)) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (DT a) (ADJP (JJ viable) (CC and) (JJ effective)) (NN recourse) (S (VP (TO to) (VP (VB lessen) (NP (NP (DT this) (NN pandemic) (POS 's)) (JJ fatal) (NNS effects)))))))))) (. .)))
